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ABSTRACT
The pharmaceutical industry depends heavily on analytical techniques for 
controlling and improving the quality of products. Development generally focuses 
on the sensitivity, selectivity, and efficiency of the technique and portability of the 
analytical instrument.
Inductively coupled plasma mass spectrometry (ICP-MS) is a well- 
established method for metal determinations. However, fewer investigations have 
focused on ICP-MS for nonmetal detection. One of the reasons is the high ionization 
energies of nonmetals. In this dissertation, the use of an ICP-quadrupole MS 
combined with ultrasonic nebulization-membrane desolvation for sample 
introduction to determine and quantify phosphorus, sulfur, chlorine and fluorine 
heteroatom-containing active pharmaceutical ingredients is presented. Detection 
limits obtained were comparable to those obtained by high-resolution instruments 
because the use of ultrasonic nebulization and membrane desolvation provided high 
analyte transport efficiency and highly efficient solvent removal ability, respectively.
Raman spectroscopy is a popular tool for qualitative determinations of 
molecular structures and properties. However, only in recent years is it being used 
for quantitative analysis with the advancements of chemometrics. In this dissertation, 
the use of dispersive Raman spectroscopy combined with multivariate calibration
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and various data preprocessing methods to quantify acetaminophen, guaifenesin, and 
phenylephrine hydrochloride is presented. The application of this method to the 
quantification of these three active pharmaceutical ingredients in an over-the-counter 
drug was successful, with absolute differences in the range of 0.3 to 3.3 % compared 
to the labeled values.
Although Raman spectroscopy is an excellent technique for chemical analysis, 
Raman instruments are traditionally stationary and bulky in size. More portable and 
lighter instruments are often required in an industrial setting. Acousto-optic tunable 
filters (AOTF) are compact solid-state devices that can be used as wavelength 
selectors. In this dissertation, the feasibility of the application of an ultra-violet 
AOTF for Raman spectroscopy is presented. High background signal from Rayleigh 
and laser scattering was determined to be the limiting factor causing the Raman 
signal to be undetectable using this ultra-violet AOTF.
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During the last decade, analytical techniques for pharmaceutical applications 
have advanced rapidly. These pharmaceutical applications reside in areas including 
discovery and synthesis of drug molecules, evaluation of the pharmacological and 
toxicological effects of pharmaceuticals, formulation of pharmaceuticals, 
determination of the metabolites of active ingredients and their impurities, and 
separation of the active ingredients from their impurities [1]. In these applications, 
quantitative analysis plays an important role.
The research in this dissertation concerns the investigation, development and 
application of various analytical methodologies to determine and quantify active 
pharmaceutical ingredients and impurities. This chapter gives an overview of the 
general motivation and direction of this research. The subsequent chapters document 
the efforts and results of the three research projects related to this general area. 
Chapter 2 describes nonmetal detection in active pharmaceutical ingredients using 
inductively coupled plasma mass spectrometry (ICP-MS) with ultrasonic 
nebulization and membrane desolvation sample introduction. Chapter 3 discusses
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2quantitative analysis of active pharmaceutical ingredients applying dispersive Raman 
spectroscopy and chemometrics. Chapter 4 presents the development of an ultra­
violet acousto-optic tunable-filter (UV-AOTF) Raman spectrometer for potential 
pharmaceutical applications. The final chapter gives an overall conclusion and 
future considerations of the development of analytical techniques for pharmaceutical 
applications.
1.2 The Need for Analytical Method Developments
There are a variety of reasons for the need of the development of better 
analytical techniques in the pharmaceutical industry. A high priority is placed on 
meeting the guidelines and regulations of the United States Food and Drug 
Administration (USFDA). It is desired to improve and control the quality of 
medicines. USFDA and other organizations around the world have maintained 
requirements and agreements for quality systems. For instance, good manufacturing 
practice (GMP) and good laboratory practice (GLP) provide the industry-specific 
guidelines to follow. GMP dictates the consistency and quality of clinical products. 
Protocols often stem from USFDA requirements. Quality standards suitable for their 
intended use are set as needed by the marketing authorization or product 
specification [2]. The principle of GLP is to promote the quality and validity of data 
obtained from nonclinical studies [2]. The results of these can help to assure the 
quality of pharmaceutical products and prevent unwanted side effects which might be
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3caused by any disqualified product. Hence, the health and safety of the consumer is 
better protected.
Another reason for the quest for better analytical methods is efficiency.
Many traditional analytical methods involve long and tedious procedures, especially 
in sample preparation. Some methods, such as the Kjeldahl method for nitrogen 
determination, can take a day for a single sample analysis [3]. The job of an 
analytical scientist is to explore less time-consuming methods that require minimal 
sample preparation. Ultimately, one would like to analyze the drug directly on the 
product line without any interruption of the manufacturing process. Recently, the 
combination of optical spectroscopy and chemometrics has provided tremendous 
improvements on these issues. For example, Aksu et al. [4] applied electronic 
absorption spectrometry and partial least squares (PLS) regression to quantify 
mepyramine maleate, lidocaine hydrochloride, and dexpanthenol simultaneously. 
Moreira and coworkers [5] applied fluorescence spectrometry and PLS regression to 
determine solid-state paracetamol and caffeine simultaneously. Candolfi et al. [6] 
employed near-infrared spectroscopy and soft independent modeling of class analogy 
to identify ten common excipients used in the pharmaceutical industry. Niemczyk et 
al. [7] applied diffuse reflectance infrared Fourier transform spectrometry and Raman 
spectroscopy with PLS regression to quantify bucindolol in gel capsules.
Besides efficiency, sensitivity and selectivity are also very important to the 
pharmaceutical industry. Usually, there is a trade-off between time (efficiency) and 
signal (sensitivity). The analytical scientist must develop techniques that maintain a 
balance between these two variables. Hyphenated or tandem methods that build
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
upon the fundamentals of individual methods can often aid in reaching such goals 
because the combination can often attain the best characteristics of the single 
methods [2], For example, Potts and coworkers [8] utilized high-performance liquid 
chromatography—nuclear magnetic resonance spectroscopy (HPLC-NMR) and mass 
spectrometry (HPLC-MS) to identify the structures of bulk drug impurities presented 
in glycinamide ribonucleotide transformylase inhibitor AG2034. Hsieh et al. [9] 
applied capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) 
to determine aristolochic acids found in Chinese herbal medicines. Lorin and 
coworkers [10] combined achiral HPLC with circular dichroism detection to analyze 
efaroxan enantiomers. Basiuk and Douda [11] applied gas chromatography Fourier 
transform infrared spectroscopy/mass spectrometry to analyze less volatile products 
of poly-L-valine pyrolysis.
1.3 General Research Direction
The general direction of this research is to investigate various analytical 
techniques for the determination and quantification of a number of pharmaceutical 
compounds. The goal of the first research project is to investigate and improve the 
sensitivity and selectivity of a hyphenated analytical technique (HPLC-ICP-MS) for 
nonmetal heteroatom detection in active pharmaceutical ingredients. The goal of the 
second research project is to explore alternative analytical methods (Raman 
spectroscopy and chemometrics techniques) for efficient detection and quantification
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5of active pharmaceutical ingredients. The goal of the final research project is to 
develop novel analytical instrumentation (UV-AOTF Raman spectrometer) for 
pharmaceutical applications.
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CHAPTER 2
DETERMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS BY 
HETEROATOM SELECTIVE DETECTION USING INDUCTIVELY 
COUPLED PLASMA MASS SPECTROMETRY WITH ULTRASONIC 
NEBULIZATION AND MEMBRANE DESOLVATION SAMPLE
INTRODUCTION
2.1 Introduction
Pharmaceutical science has advanced greatly in recent years. Pharmaceutical 
compounds are becoming more complex. These kinds of compounds are no longer 
only small molecules containing carbon, hydrogen, oxygen and nitrogen. 
Heteroatoms such as phosphorus, sulfur, chlorine, and fluorine may also be present 
in these compounds [12]. Therefore, nonmetal detection and quantification of 
pharmaceutical compounds have become more demanding. In the past, atomic 
spectroscopic techniques such as flame atomic absorption and emission mainly dealt 
with trace metal detection. Recent developments of science and technology have led 
to the possibilities of trace nonmetal detection. The development of inductively 
coupled plasma mass spectrometry (ICP-MS) can be categorized as a major 
cornerstone for trace nonmetal detection.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
This chapter documents the application of ICP-MS with a combination of 
ultrasonic nebulization and membrane desolvation (USN-MD) sample introduction 
for nonmetal detection. The quantification of four active pharmaceutical ingredients 
is shown. The first section of this chapter gives a brief background on ICP-MS and 
sample introduction methods. The second part describes research that has been 
performed using ICP-MS for nonmetal speciation and the goals and focus of this 
research. The third part presents the experiments and discussion of the results 
generated from this research. The final few pages contain the conclusion and future 
outlook of this research.
2.2 Background of Inductively Coupled Plasma
The argon inductively coupled plasma was first developed as an emission 
source for analytical instruments in the 1960s by Fassel and coworkers in the United 
States and by Greenfield and coworkers in England [13]. An ICP is an electrical 
discharge that looks somewhat like a flame. However, the temperature of an ICP is 
much higher than flames formed by traditional fuels and oxidants. An ICP consists 
of a torch, an induction coil, a radio frequency (RF) generator and plasma gas 
(Figure 1). The torch is usually made of three concentric quartz tubes. To form an 
ICP, a tangential flow of argon is channeled between the outer and the middle tube of 
the torch. This is sometimes called the “coolant” gas because it also acts as a cooling 
agent for the torch. The flow rate of this gas is generally between 12 and 16 L/min.
A second flow of argon gas is directed between the middle and the inner tube of the




Figure 1. Basic components of inductively coupled plasma (adapted from [14]).
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9torch. This “auxiliary” or “plasma” gas can be used to vary the vertical position of 
the base of the plasma [14]. The auxiliary gas flow rate is usually between 0.5 and 1 
L/min. Another argon gas flow is passed through the inner tube of the torch and acts 
as the “carrier” gas for the sample. The flow rate of this gas is usually around 
1 L/min. Radio frequency power, usually at 27 MHz and around 1000 W, is applied 
to the induction coil. This electrical field induces an oscillating annular magnetic 
field in the region of the torch. To ignite the discharge, a high-potential spark is 
produced by a Tesla coil located in the vicinity of the torch. Electrons from the spark 
are accelerated by the magnetic field. When the alternating current reverses direction, 
the direction of the magnetic field is also reversed; this causes the accelerated 
electrons to move in the reverse direction. The result is multiple collisions between 
the argon molecules and the free electrons, causing argon ionization and the 
generation of more electrons. These electrons continue colliding with the rest of the 
argon molecules and producing more argon ions. This coupling process continues 
and results in the formation of plasma at the end of the torch. This ICP can be 
sustained as long as RF power and argon are supplied to the induction coil and the 
torch, respectively [13, 14]. The complete process of ICP formation is illustrated in 
Figure 2.
2.3 Background of Inductively Coupled Plasma Mass Spectrometry
After the introduction of ICP as a new analytical atomic source, researchers 
began to develop ICP atomic emission spectrometry (ICP-AES). In 1975, the first


















Figure 2. Mechanism of the generation of inductively coupled plasma, (a) Tangential 
argon flows through the torch, (b) Induced magnetic field formed by the applied RF 
power, (c) High-potential spark initiates the inductive coupling process, (d) An ICP 
is formed at the end of the torch.
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commercial ICP atomic emission spectrometer was introduced [13]. The high gas 
and electron temperature and high electron density also make the ICP an ideal 
ionization source [15]. During the 1970s, researchers began to explore the 
possibility of using ICP as an ion source for mass spectrometric elemental analysis. 
The first commercial ICP-MS instruments were introduced in 1983 [16]. These were 
low-resolution instruments utilizing quadrupole mass analyzers. For elemental 
analysis, resolution of < 300 is usually adequate. Therefore, these instruments 
remain the most common. In the following years, high-resolution instruments using 
magnetic sector field mass analyzers became available in the market [16]. The basic 
components of an ICP-MS instrument include sample introduction, the ICP, the 
interface region, ion optics, mass analyzer and detector (Figure 3). The interface 
region serves as a transition area between the atmospheric pressure ICP and high- 
vacuum mass analyzer. A well-designed interface minimizes the secondary 
discharge effect and the spread of ion kinetic energies. The ion optics are a set of 
electrostatic lenses which selects and guides the appropriate positive ions to the mass 
analyzer. A well-controlled ion optical system can reduce space charge effects, 
background signals and noise.
A critical step in ICP-MS operation is sample introduction. In many cases, 
sampling performance limits the sensitivity and selectivity of the system. This is true 
especially for low-resolution ICP-MS systems.
Samples can be introduced as gases, liquids, or solids. Gaseous samples can 
be introduced into the ICP directly, by hydride generation, or by gas 
chromatographic methods. Gaseous sample introduction has the advantages of high
























Figure 3. Schematic of a typical ICP-MS instrument.
13
transport efficiency and almost no matrix effects. However, the major disadvantage 
is that the steps for gaseous sample generation are usually time consuming and 
additional apparatuses and chemicals may be needed. Solid samples can be 
introduced into the ICP by a number of means, including direct sample insertion, 
electrothermal vaporization, and laser ablation. Of these, the most popular and well- 
developed method is laser ablation due to recent advances in laser technology. This 
method possesses several advantages such as minimal sample consumption and high 
sensitivity. Some drawbacks may include the high cost of the instrument and 
heterogeneity of samples [15].
Despite the rapid development in solid sample introduction, the most popular 
types of sample introduction systems are still for liquid samples. The simplest and 
most common liquid introduction device is the pneumatic nebulizer (PN). The 
purpose of a nebulizer is to generate an aerosol of the liquid sample. The two basic 
types of PNs, concentric and crossflow, are classified by the relative direction of the 
gas flow and sample solution. However, the aerosols produced by these nebulizers 
are very coarse and disperse in droplet size. A spray chamber is commonly utilized 
to remove the larger droplets and introduce to the plasma a more uniform and fine 
droplet size distribution. A common spray chamber is the double-pass type. The 
major advantages of PN are their simple design and low cost. There are a number of 
disadvantages such as low transport efficiency (<1%) and clogging.
Ultrasonic nebulizers (USN) may be used to solve some of the 
aforementioned problems. Through a capillary tube, the sample solution is directed 
to the surface of a piezoelectric transducer. An aerosol is formed by the acoustic
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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energy transferred to the liquid sample. Argon is used to transport these aerosols 
through the spray chamber, where the larger droplets are removed. Since a higher 
aerosol production rate is attained by the USN, desolvation is needed to remove 
excess solvent and prevent plasma cooling or extinguishment. This can be achieved 
by passing the sample aerosol through a heated U-tube (usually at or near 140 °C) 
and cooled condenser (usually at 0 to 5°C) (Figure 4). The USN has advantages of 
high nebulization efficiency and little or no clogging. However, there are some 
drawbacks such as high sample volume and high cost.
A more advanced desolvation method is membrane desolvation. With this 
technique, the analyte-containing aerosol is directed through a heated membrane 
system where the solvent is evaporated and the analyte particulates are obtained.
The solvent vapor then diffuses through the membrane and is removed by a 
countercurrent gas flow to a waste stream. The analyte particulates that do not pass 
through the membrane are transported to the plasma (Figure 5).
2.4 Survey of Nonmetal Determinations by Inductively Coupled Plasma Mass
Spectrometry
Inductively coupled plasma mass spectrometry has become a very popular 
method for trace metal analysis due to its high sensitivity and selectivity. However, 
compared to that for metals, the analytical performance for nonmetal detection is 
somewhat degraded because of the high ionization energies of nonmetals. The 
equilibrium of this ionization process is shown below:
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M  <-»■ M' + e
The equilibrium constant can be obtained in Equation 2.1:
K , = — -  (2.1)
nM
where nM+ is the number density of ions, nM is the number density of atoms, and ne is 
the number density of free electrons. Kt is the equilibrium constant and can be 
estimated using the Saha equation [13]:
log K t = 15.684 + log ^ -  + 1.5 log T - ^ ^ -  (2.2)
T
where Z, are the partition functions for ion and atom, T is the temperature and Et is 
the ionization energy of the atom [13]. As Equations 2.1 and 2.2 show, higher 
ionization energies lead to smaller equilibrium constants and, hence, fewer ions are 
generated at a given temperature. For example, at 7500 K and an electron density of
1C 1
10 /cm , the ionization efficiencies are estimated to be over 90 % for most metals. 
However, only 0.0009 % of fluorine will be ionized under these conditions [17].
In addition, isobaric interferents can be generated from the solvent matrix and 
cause spectral interference to the analyte ion. For example, 16(>2+ overlaps with the 
major isotope of sulfur (32S). Table 1 shows some of these potential interferents for 
fluorine, phosphorus, sulfur, and chlorine.
Different approaches have been developed to address the problems with 
nonmetal detection by ICP-MS. Basically, the goals are to decrease the effects of 
spectral interferences and increase analyte transport efficiency. Methods include 
using high-resolution mass spectrometers [18-21], applying prequadrupole collision
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Table 1. Possible interferents for F, P, S, and Cl
Isotope
Natural Interfering fraction of
Element Isotope abundance species interferent3


















Sulfur 32s 0.95 160 160 + 0.995








Chlorine 35C1 0.7553 “ o ' W 0.00199






aThese values were calculated by the products of the fractional natural abundance of 
the isotopes.
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cells [22], using mixed gas [23] and low-pressure helium plasmas [24, 25], and 
utilizing different nebulization and desolvation techniques [26].
High-resolution (HR) mass spectrometers use magnetic sector MS to separate 
ions with the same nominal mass based on their mass defects. For example, Bu et al. 
[18] demonstrated that 19F+ (18.9984) can be differentiated from (19.00699)
using an HR instrument. They obtained substantial detection limit improvements for 
chlorine and fluorine. Detection of sulfur [19, 20] and phosphorus [21] was also 
demonstrated by other researchers. Although HR instruments can provide higher 
mass resolution, there are some disadvantages. HR instruments are usually larger 
and require lower operational pressure. Further enhancement of resolution may 
increase ion loss and limit the sensitivity of the instrument [18].
The use of collision and reaction cells can reduce spectral interferences 
and/or allow the separation of the analyte ion peak from the interferent by the 
formation of molecular ions inside the cell. Interaction between analyte ions and an 
appropriate gas inside the cell can induce ion neutralization, charge transfer, and/or 
formation of molecular ions [27], The detection of phosphorus [28] and sulfur [28, 
29] as their oxide ions was illustrated using this method. The drawbacks of this 
method include increased complexity and ion loss that may reduce sensitivity.
Helium and mixed-gas ICP have been used to reduce polyatomic 
interferences and improve nonmetal ionization [23-25]. The use of helium for ICP 
may provide better detection limits for nonmetals because of higher energies of 
helium plasma species. However, there are several disadvantages of using mixed 
gases and helium as the plasma gas. For instance, it is more difficult to form and
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maintain a helium plasma because of the high thermal conductivity of helium. 
Secondary discharge formation is also more common with the helium plasma 
because of its lower temperature and electron density. This is, by far, the limiting 
factor for the detection of nonmetals [15]. As the major background ions present in a 
helium plasma are low-mass ions [30], this may cause further interference problems 
with the detection of low-mass nonmetals such as fluorine. If a commercial argon 
ICP-MS is to be used as a helium ICP-MS, major modifications on the impedance 
matching network and the load coil may be required. In addition, repositioning of 
the sample and skimmer cones may be needed to obtain optimum performance.
Improvement of the transport of analyte also has the potential to improve 
nonmetal detection. One method in particular is the use of an ultrasonic nebulizer 
combined with membrane desolvator (USN-MD). Axelson et al. [26] used USN-MD 
for HPLC-ICP-MS to determine phospholipids in organic solvents. Carnahan et al. 
[31-33] had success in using USN-MD as the sample introduction method for HPLC 
and microwave-induced plasma atomic emission spectrometry to determine chlorine- 
containing organic compounds.
2.5 Research Direction
The goal of this research project is to investigate and improve the sensitivity 
and selectivity of inductively coupled plasma mass spectrometry for nonmetal 
heteroatom detection in four active pharmaceutical ingredients. The focus is to 
characterize the analytical performance of the ultrasonic nebulization—membrane
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desolvation combination for sample introduction using a low-resolution argon ICP- 
MS. The analysis of phosphorus, sulfur, chlorine, and fluorine is examined.
2.6 Experimental Setup and Instrumentation
A schematic diagram of the experimental system for ICP-MS is shown in 
Figure 6. The following paragraphs describe the details in sample preparation, 
sample introduction and the ICP-MS system.
2.6.1 Sample Preparation
The active pharmaceutical ingredients of interest and their target heteroatoms 
examined in this research are phosphomycin (P), amoxicillin (S), chlorpropamide 
(Cl), and ofloxacin (F). Phosphomycin is an antibiotic used to treat urinary-tract 
infections. Amoxicillin is an antibiotic used to treat several bacterial infections such 
as pneumonia, bronchitis, gonorrhea, and infections of the ear, nose, throat, urinary 
tract, and skin. It can also be used with other medications to remove H. pylori, a type 
of bacterium that causes ulcers. Chlorpropamide is a drug used to treat Type II 
noninsulin-dependent diabetes. Ofloxacin is an antibiotic similar to amoxicillin; it is 
used to treat several bacterial infections causing pneumonia, bronchitis, and venereal 
diseases, as well as prostate, skin, and urinary-tract infections [34], The structures of 
these compounds are shown in Figure 7. An 80 ppm phosphorus-containing stock 
solution was prepared by dissolving 113.7 mg of phosphomycin calcium salt (Sigma-














































Figure 6. Schematic diagram of experimental system. The dotted box indicates the ICP-MS unit.
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Aldrich, Milwaukee, WI) in 250 mL of deionized water. A 50 ppm sulfur-containing 
stock solution was prepared by dissolving 142.5 mg of amoxicillin (Sigma-Aldrich, 
Milwaukee, WI) in 250 mL of aqueous 0.2 % nitric acid. A 60 ppm chlorine- 
containing solution was prepared by dissolving 117.1 mg of chlorpropamide (Sigma- 
Aldrich, Milwaukee, WI) in 250 mL of aqueous 0.02 M potassium hydroxide. A 500 
ppm fluorine-containing solution was prepared by dissolving 951.0 mg of ofloxacin 
(Sigma-Aldrich, Milwaukee, WI) in 100 ml aqueous 4 % ammonium hydroxide. The 
stock solutions were used to prepare diluted solutions with appropriate solvents for 
analyses. HPLC-grade methanol (Sigma-Aldrich, Milwaukee, WI) and 18 MQ-cm 
deionized water obtained with a Millipore Systems (Billerica, MA) Milli-Q Plus 
deionization system were used for sample preparation.
2.6.2 Sample Introduction System
Flow injection sample volumes of 100 to 300 pL were introduced to a 
CETAC U5000 ultrasonic nebulizer (CETAC Technologies, Omaha, NE) using a 
Gilson Minipuls3 peristaltic pump (Gilson, Inc., Middleton, WI). The liquid flow 
rate was 0.9 mL/min. While maximum steady-state signals were not obtained with 
this approach, the limited sample volumes prevented analyte residue from building 
up within the system and allowed multiple parameters to be adjusted in reasonable 
time frames. Following the heating-condensation USN apparatus, the aerosol was 
further desolvated utilizing a CETAC MDX-100 PTFE membrane desolvator.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
25
Operational parameters are listed in Table 2. The desolvated samples were 
transported to the ICP by the argon gas.
2.6.3 Inductively Coupled Plasma Mass Spectrometry and Data Acquisition
A Fisons (Thermo Electron, Madison, WI) Instruments PlasmaQuad II ICP- 
MS was used to perform mass analyses. The detector was a Burle Electrooptic, Inc. 
(Sturbridge, MA) channeltron model number 4870V electron multiplier. Data was 
acquired utilizing Thermo Electron PlasmaLab software (Version 1.06.007, Ionflight, 
Boston, MA). Both the single ion monitoring and scanning modes were used. Mass 
spectra (scanning mode) were obtained to confirm the peak positions for each 
element. Background and analyte signals were determined using 30-second single­
ion monitoring observations at a rate of 250 ms/point. Detection limits were 
calculated as the concentrations giving a signal three times the standard deviation of 
the background signal. ICP-MS and data acquisition parameters are summarized in 
Table 2.
2.7 Background Interferences and Isotope Selection
The detection limit and sensitivity for many elements in ICP-MS, especially 
low-mass nonmetals, are greatly affected by the interferents present at the particular 
mass-to-charge value. The background ion signal depends on the plasma chemistry, 
which varies with operational conditions, matrix composition, and the argon purity.
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Table 2. ICP-MS and sample introduction operational parameters
Sample introduction
Peristaltic pump liquid sample introduction flow rate 0.9 mL/min
Sample volume 100-300 pL
Ultrasonic nebulizer argon flow rate 0.62 L/min
Post ultrasonic nebulizer flow stream heater temperature 140 °C
Post ultrasonic nebulizer flow stream condenser temperature 3 °C
Membrane desolvator countercurrent argon flow rate 1.9 L/min
Membrane desolvator flow stream heater temperature 160 °C
Inductively coupled plasma mass spectrometer
Argon plasma gas flow rate 0.8 L/min
Argon plasma coolant flow rate 14.0 L/min
Forward power8 Fluorine: 1500 W 
Phosphorus: 1000 W 
Sulfur: 1200 W 
Chlorine: 1000 W




Data acquisition mode Single ion-pulse 
counting
Data acquisition dwell time 250 ms
aDiscussions regarding forward power and isotope selection are contained in 
the text.
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The analyte solution may contain high concentrations of interfering ions or a 
combination of elements that combine under the correct conditions to produce high 
molecular ion background signals.
Elimination of solvent interferents requires complete desolvation of the 
analyte stream so that only dry particulate analyte molecules are transported to the 
plasma. Solvent transport measurements [31] and molecular emission spectra [32, 33] 
illustrate that high solvent removal efficiency can be achieved by membrane 
desolvation coupled with ultrasonic nebulization.
However, solvent removal is never 100%. Mass spectra taken at the m/z 
values corresponding to the nonmetals with nebulized solvent with and without the 
analyte are shown in Figures 8-11. The signal at m/z of 32 was unusable for the 
dominant ion of sulfur due to the high background signal caused by the dioxygen ion, 
16C>2+. However, the background signal is under 200 counts per second for the less 
abundant 34S species. 35C1 is the most abundant chlorine isotope; it gave the best 
signal-to-noise ratio with a background signal under 5000 counts per second. The 
signal-to- noise ratio was worse for the Cl isotope, possibly due to the higher 
background noise caused mainly by the 36Ar'H+ ion and the lower abundance of this 
isotope. The background was significant for the monoisotopic species 31P and 19F.
At m/z = 31, it is likely that the significant background is caused by the nitrogen ion 
compounds (^N ^O 'H ^ and products of methanol decomposition (12C160 'H3+). At 
m/z = 19, it has been shown that background contributions from 160 1H3+ and lsO'H+ 
are dominant [19]. Examinations of the ratios of the small background signals at m/z 
equal to 19 and 20 indicate that 38Ar+2 is not a significant interferent.
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Figure 9. Mass spectrum of sulfur (580 ppb S as amoxicillin). Lower and upper lines indicate background and analyte peaks,
respectively. K>
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Optimization of the phosphorus-31 signal, introduced as phosphomycin in a 
20% methanol in deionized water solution, consisted of varying gas flow rates and 
the forward power to maximize the signal-to-noise ratio. Because phosphorus can be 
significantly ionized under typical plasma operating temperatures, 33% as estimated 
by Houk [17], the plasma provides a relatively large abundance of ions for 
measurement. As seen in Table 3, the detection limit is reasonably low at 1.7 ppb. 
That the detection limit does not contend with those of metals with similar ionization 
energies may be due to analyte decomposition issues; phosphorus atomization of 
phosphomycin requires multiple oxygen-phosphorus bond breakages. However, this 
speculation is countered by the absence of significant PO+, PC>2+, or PC>3+ signals. In 
the presence of phosphorus, a significant yet lower signal at m/z 48 was seen. It is 
likely that this signal is due to 3IP160 1H+. Phosphorus detection limits for this and 
other continuous liquid sample introduction ICP-MS approaches can be seen by 
examination of Table 4. In all cases, the present detection limit using the USN-MD 
is superior. The improvement compared to other published values [17, 21, 24, 35] 
may be attributed to enhanced desolvation of the analyte stream, which limits plasma 
cooling and minimizes the formation of polyatomic interferents. Utilizing pulse 
counting, the calibration plot (Figure 12a) was linear from 20 to 800 ppb with an R2 
value of 0.9991. Using analog detection, the range could be extended from 800 to 
4000 ppb with an R2 value of 0.999990 (Figure 12b).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
33










Phosphomycin 31P 20 % MeOH 20700 0.3 2
Amoxicillin 34S 20 % MeOH 1800 0.3 3
Chlorpropamide 35C1 0.1 %
CH3COONH4
400 9 90
Ofloxacin 19f 4 % NH3 0.55 1000 3000
aAqueous solvent mixture with specified components 
bicps = integrated counts per second













Table 4. Detection limit comparison for continuous sample introduction methods
Degree of Plasma Mass
Element ionization gas______ spectrometer
Fluorine 9 x l 0 '6 Ar quadrupole
quadrupole
Ar sector
Phosphorus 0.33 Ar quadrupole
Ar quadrupole
Ar quadrupole
t o r f  quadrupole
Ar sector
Sample Monitored Detection limit
introduction8 species (ng/mL) Reference







USN-MD 31P 2 this work
USN 31P 8 35




PN 31P 65 21















Degree of Plasma Mass Sample Monitored Detection limit
Element ionization gas spectrometer introduction3 species (ng/mL) Reference
Sulfur 0.14 Ar quadrupole USN-MD 34S 3 this work
Ar quadrupole USN 34S 150 35
He (5 
torr) quadrupole capillary USN
34S 4,000 24
PN with an 34S
Ar quadrupole octopole 
reaction cell
1.3 22
Ar sector Micro-concentric PN
32S 1 20
Ar sector PN 32S 0.6 19































Figure 12. Calibration plots of phosphorus, (a) Pulse-counting detection, (b) analog 
detection.




The use of the most abundant isotope for sulfur ( S) was precluded due to 
the large 16C>2+ ion background (Table 1). Although the mass 34 isotope is much less 
abundant (4.2%), the decrease in the background ion count produced signal-to-noise 
ratios superior to those achieved using the mass 32 isotope. Some interferences are 
still present at mass 34 (Table 1); however, the net effect is a relatively small 
background signal (Figure 9). Operation of the plasma at 1200 W provided the best 
signal-to-noise ratios for sulfur. This power served to enhance the ionization of 
sulfur, which is ionized only 14% based upon Houk’s [17] previously calculated 
values. The detection limit was determined to be 3.3 ppb and is listed in Table 3. 
This sulfur detection limit was superior to values obtained with standard ICP 
quadrupole mass spectrometers without interface modifications. It should be noted 
that the use of a prequadrupole octopole dynamic reaction cell [22] or a sector mass 
spectrometer [19, 20] produced somewhat better detection limits. The trade-off of 
the relative complexities of high-resolution mass spectrometry with ultrasonic 
nebulization and membrane desolvation must be made. Utilizing pulse counting, the 
calibration plot was linear from 10 to 1000 ppb (Figure 13a) with an R2 value of 
0.998. Using analog detection, the plot became nonlinear and rolled over (Figure 
13b) at concentrations higher than 5000 ppb. This phenomenon may be due to the 
saturation of the detector.
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Figure 13. Calibration plots of sulfur, (a) Pulse-counting detection, (b) analog 
detection.
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2.10 Chlorine Determination
The most abundant chlorine isotope, 35C1, was monitored because this isotope 
is relatively free of interferences as seen in Figure 10. Bu et al. [18] noted similar 
behavior. With the fairly low calculated ionization efficiency for chlorine, -0.9% 
[17], higher ICP forward powers were initially used when examining the 
chlorpropamide-containing samples. However, the increase in forward power 
resulted in an increase in the background ion signal and noise, thus degrading 
detection limits. Based upon available information, the nature of this interference is 
not clear. The optimal plasma power for chlorine detection was determined to be 
1000 W. A detection limit of 90 ppb was obtained (Table 3). Utilizing pulse
'y
counting, the calibration plot was linear from 180 to 60 000 ppb with an R value of 
0.99991 (Figure 14).
No other chlorine detection limits with direct solution sampling into a 
standard argon ICP quadrupole mass spectrometer system were found in the 
literature. Again, that chlorine was detectable at these levels is attributed to the 
USN-MD system. Using a sector mass spectrometer, Bu et al. [18] obtained 
detection limits of 3 ppb. Sheppard et al. [23] were able to reduce detection limits to
2.2 ppb with a mixed argon-helium plasma.
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Figure 14. Calibration plot of chlorine using pulse-counting detection.
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2.11 Fluorine Determination
Fluorine has the highest ionization energy of all the halogens with a 
calculated ionization efficiency of only 0.0009 % [17]. Furthermore, with significant 
water and argon-derived interferences possibly present at the mass of its only isotope, 
fluorine-19, determinations have presented a significant challenge for ICP-MS 
spectroscopists. Even with MD in the present study, the background signal was 
significant. Increasing the forward power to 1500 W served to maximize the signal- 
to-noise ratio by enhancing the fluorine ion signal. Forward powers exceeding 1500 
W increased the background noise without further significant increases in the 19F+ 
signal.
Although this is the first report of solution sample introduction directly into a 
conventional ICP-MS system, the detection limit of 3.3 ppm is high compared to the 
other nonmetals discussed in this research. As illustrated in Table 4, this value is 
comparable to, or slightly better than, published results using a low-pressure helium 
ICP [24] or an argon plasma with a sector mass analyzer [19]. While the sector 
instrument produced higher resolution than the quadrupole mass spectrometer used 
in this study, it can be presumed that the sector MS trade-off between higher 
resolution with reduced ion flux and reduced water-derived interferences with 
membrane desolvation is the reason that our detection limits are comparable.
Utilizing pulse counting, the calibration plot was linear from 50 to 200 ppm with an 
R value of 0.98. At higher concentrations, the calibration plot rolled over. More
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detailed studies of this phenomenon are required to fully understand the cause of this 
rollover.
2.12 Summary and Future Directions
This research demonstrates the determination and quantification of 
phosphorus, sulfur, chlorine and fluorine heteroatom-containing active 
pharmaceutical ingredients using inductively coupled plasma mass spectrometry 
combined with ultrasonic nebulization and membrane desolvation for sample 
introduction.
A general trend of decreasing detection limits with increasing ionization 
efficiency was observed. Detection limits for 31P (phosphomycin), 34S (amoxicillin), 
35C1 (chlropropamide), and 19F (ofloxacin) of 2, 3, 90, and 3000 ppb, respectively, 
were obtained. These values are either comparable to or better than those obtained 
with other ICP-MS systems, including high-resolution instruments. Such low 
detection limits can be credited to the use of USN and MD for their high analyte 
transport efficiency and highly efficient solvent removal ability, respectively. The 
use of USN and MD provides a simple and effective method to enhance the 
analytical performance for the determination of nonmetals in APIs using ICP-MS.
Ultimately, this research paves the road for the combination of high- 
performance liquid chromatography and ICP-MS in the separation and quantification 
of APIs and their impurities. The addition of HPLC improves the selectivity of the 
technique. However, using organic solvent and buffer salts is common in HPLC.
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High organic content can result in high carbon concentration. This excessive carbon 
may cause problems in ICP-MS such as carbon deposition on sample and skimmer 
cones. This problem may be corrected by post-column solvent modification or 
dilution and/or utilization of a better desolvation system. A better desolvation 
system can be achieved by more detailed studies of the membrane desolvator. For 
instance, the physical properties of the membrane desolvator may be modeled 
empirically and mathematically. Such a model may be used to predict the transport 
behavior and efficiency of future analyte and solvent.
Although quantification was successful in this research, there is room for 
future improvement. All analytical instruments suffer from a range of fluctuations 
over time; ICP-MS is not exempt. For ICP-MS, these fluctuations include drift of 
m/z ratio, optimum torch position, power, and matrix effects. To improve the quality 
and robustness of the calibration, one can use internal standards and multivariate 
methods.
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CHAPTER 3
QUANTITATIVE ANALYSIS OF ACTIVE PHARMACEUTICAL 
INGREDIENTS BY RAMAN SPECTROSCOPY AND CHEMOMETRICS
3.1 Introduction
One of the criteria in pharmaceutical analysis is efficiency. Development of 
analytical techniques that require less time and labor is in high demand because 
higher productivity could mean better competitiveness. The goal in the 
pharmaceutical industry is to analyze drugs directly on the product line without any 
interruption of the manufacturing process. Although inductively coupled plasma 
mass spectrometry is a very sensitive technique, it is rather time consuming in terms 
of sample preparation, experimental setup, parameter optimization, and 
instrumentation maintenance. Raman spectroscopy is one of the candidates for 
efficient quantitative analyses of active pharmaceutical ingredients. Multivariate 
calibration can be used to enhance the selectivity during the quantification process.
This chapter documents the use of dispersive Raman spectroscopy and 
chemometrics for quantitative analysis of active pharmaceutical ingredients of 
common cold medicines. The quantification of three active pharmaceutical 
ingredients is shown. The first section of this chapter gives a brief background of
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Raman spectroscopy and chemometrics. The second part describes research that has 
been performed using Raman and other analytical techniques for quantification of 
pharmaceutical compounds and the goals and focus of this research. The third part 
presents the experiments and discussion of the results generated from this research. 
The final few pages contain the conclusion and future outlook of this research.
3.2 Background of Raman Spectroscopy
The Raman effect was first predicted by Smekal in Germany in 1923 and first 
observed by C. V. Raman in India in 1928 [36]. The first experiments were 
performed using sunlight as the excitation source, simple glass filters, a telescopic 
collector, and visual detection [36, 37]. Later, Raman performed experiments by 
using a mercury lamp and a spectrograph. Large amounts of sample and time were 
needed to obtain measurable spectra [36]. Since Raman is a very weak phenomenon, 
a strong monochromatic light source is vital to Raman detection. Light source 
developments became the main topic in early research efforts. The first Raman 
instruments adapted mercury lamps from atomic emission spectrometers as 
excitation sources. Different lamps have emerged from various manufacturers. For 
instance, the Toronto Arc introduced by Welsh et al. in 1952 represented a major 
improvement in Raman excitation source technology [37]. The lamp was a four-turn 
helix of Pyrex glass which can radiate as much as 50 W at the 435.8 nm emission 
line of mercury. However, the device is relatively inefficient and only a small 
fraction of this power can be used for excitation [36]. The introduction of lasers in
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the 1960s changed the pace of Raman instrumentation development. The 
monochromatic, highly directional, coherent, and high irradiance output of a laser 
make it a very suitable excitation source for Raman spectroscopy. The first 
commercial models employed the He-Ne laser (632.8 nm). Later ion lasers such as 
the argon ion laser (various lines from 351.1 to 514.5 nm) and the krypton ion laser 
(various lines from 337.4 to 676.4 nm) became available. These devices produced 
excitation wavelength in the visible and ultra-violet spectral regions [37]. In recent 
years, the Nd:YAG (1064 nm) laser has become a popular source for the Fourier 
transform instruments [36].
The first Raman spectrometers used cumbersome photographic plates as 
detectors. Later, phototubes and photomultiplier tubes were introduced and 
improved the sensitivity of Raman detection. Multichannel detectors such as charge- 
coupled devices (CCD) have become popular in recent years and have further 
increased the efficiency of Raman radiation collection. The early Raman 
spectrometers often used a single monochromator with a replica grating. Currently, 
Raman spectrometers are usually equipped with a double or triple monochromator 
with high-quality coated mirrors to reduce stray light effects and holographic 
gratings to eliminate any artifacts associated with low-quality replica gratings. 
Modem Raman instruments are also controlled by computers and are capable of 
remote control and fast data analysis with advanced software systems.
A typical Raman spectrometer consists of an excitation source, sample 
illumination and scattering collection optics, wavelength selector, and detection 
system. In modem Raman instruments, the excitation source is a laser. Modem
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Raman instruments employed a large range of lasers, from ultra-violet (UV) to near- 
infrared (NIR). Most commercial dispersive instruments use a visible laser such as 
the very common He-Ne laser, the air-cooled argon ion laser, or a compact diode 
laser (785 nm). For Fourier transform (FT) instruments, the solid-state Nd:YAG 
laser (1064 nm) is more common. Custom instruments can be equipped with a UV 
laser such as a He-Cd laser (325 nm) [38] or a tunable laser for different applications 
[39, 40], Recently, the more user-friendly optical parametric oscillator (OPO) lasers 
have replaced the traditional tunable dye lasers and have gained popularity as a 
tunable source for Raman applications [41, 42],
A lens or group of lenses is often used to focus the laser beam to the sample 
to increase the irradiance and decrease the sampling size. A laserline bandpass filter 
is essential to remove any unwanted plasma lines arising from the generation of the 
monochromatic laser. Raman scattering can be collected in several configurations. 
The most common ones are the 90-degree and 180-degree (backscattering) 
geometries. There are advantages and drawbacks to both configurations. For 
instance, the 90-degree geometry can be set up easily but the 180-degree geometry is 
less susceptible to reabsorption of radiation by the sample. Rayleigh scattering is a 
kind of elastic scattering because there are no energy differences between the starting 
and final energy levels. Since Rayleigh scattering is much more intense than Raman 
scattering, Rayleigh rejection filters cannot be omitted from any Raman system. 
Holographic notch filters offer narrow bandwidth (<350 cm'1) and high attenuation 
(>106) of the laser line [43]. Recent advances in thin-film deposition technologies
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provide edge filters that give even better signal transmission (>93%) and steeper 
edges (0.5 % of laser line) [44].
Grating monochromators are still the most popular type of wavelength 
selector for dispersive Raman spectroscopy. Double or triple monochromators are 
usually used to reduce stray light effects. The gratings are often blazed at a 
wavelength close to that of the laser to increase the efficiency of the monochromator. 
The mirrors can also be coated according to the wavelength range of the Raman 
scattering. FT Raman instruments are similar to those used in infrared spectroscopy. 
They possess the fundamental advantages of any FT instrument; the multiplex and 
the throughput advantages. Furthermore, they are less susceptible to fluorescence of 
the sample, laser-induced thermal damage, self-absorption, and laser frequency shift. 
However, vibrational overtones and combination absorption bands from O-H, C-H, 
or N-H stretching in the Stokes Raman region (1070 -  1700 nm) of an FT Raman 
instrument can be significant and interfere with the Raman features [45], The 
solvent may also absorb in this region and cause significant increase in sample 
temperature and hence affect the integrity of the sample and spectrum [45],
Photomultiplier tubes (PMT), CCD, and photoconductive detectors are 
among the most common detectors used in Raman spectroscopy. PMTs are the 
oldest type of detectors. The advantages of PMTs include high gain, low noise, and 
short response time. However, they are less popular in recent years due to their 
single-channel nature. CCDs became more popular for dispersive Raman 
instruments because of their multichannel nature, high quantum efficiency in the 
visible region, and imaging capability. Photoconductive type detectors such as
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InGaAs detectors are often used in FT instruments because of their high efficiency 
and low noise in the NIR region.
The Raman effect can be described by both classical and quantum mechanical 
theories. Classical theory is more intuitive; however, quantum theory is more 
accurate. Both descriptions are stated in the following pages.
In classical theory, light can be described as a wave-like electromagnetic (EM) 
field. When this EM field is applied to a molecule, polarization can be induced 
within the molecule and scattering of the light is results. The magnetic field of this 
light source can be ignored for applications where the frequency of light is lower 
than that of X-ray [46]. For a single molecule, the induced dipole moment (n) can be 
described by Equation 3.1:
H = a - E  (3.1)
where a is the polarizability tensor and E is the applied electric field vector [41]. For
an ensemble of molecules, Equation 3.1 becomes
P = / . E  (3.2)
where P is the polarizability vector and /  is the susceptibility tensor [46].
However, if the electric field is large enough, dielectric breakdown occurs and higher 
terms are needed to describe the total polarizability:
P = X(I).E + x(2).E2 + x(3).E3 + ... + x0)-E' (3.3)
where x 0) are functions of the state of the molecule, frequency of oscillation and 
vibrational motion of the molecule [46]. Hence, polarizabilty or susceptibility
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changes with the vibrational motion of the molecule. The changes are very small, so 
they can be expressed as the Taylor expansion:
« = « o + ( |§ ) . - *  + .....  (3-4)
where ao is the equilibrium polarizability and X is the vibrational coordinate [46], 




The first term of Equation 3.5 is independent of vibrational motion, X, and has the 
same frequency dependency as the applied electric field. This term describes 
Rayleigh scattering. The second term is dependent of vibrational motion. This term 
describes normal Raman scattering [46].
If the electric field and the vibrational coordinate oscillate as a cosine 
function in time, they can be expressed as
E = Eocos(cot) (3.6)
and X  = Xocos(covt) (3.7)
where Eo is the equilibrium electric field, Xq is the equilibrium position of the 
molecule, co and cov are the angular frequencies of the electric field and normal 
modes respectively, and t is time [46]. Inserting Equations 3.6 and 3.7 into Equation 
3.5 and preserving the second term only gives
doc
v  = 'X o ■ E0(coscovt)(cosa)t) (3.8)
oX
Since cos(x)cos(y) = 0.5(cos(x+y) + cos(y-x)), Equation 3.8 can be written as
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1 Qcc
^  = - { — )o 'x o -^otcosC^ + ^ v ) '+ cos(ffl-<»vXI (3.9)
2 oX
The first term of Equation 3.9 describes anti-Stokes Raman scattering; the second 
term describes Stokes Raman scattering [46]. From classical electrodynamics, the 
radiant flux (I) of an individual scatterer is given by [47]
/  = Mo V K (3.10)
2 c 3£ 0
where /no is the amplitude of n, v is the frequency of applied electric field, c is the 
speed of light, and eo is the vacuum permittivity. This implies that the ratio between 
the intensities of the Stokes and anti-Stokes Raman scattering is (v-vv)4/(v+vy)4, 
which is not correct.
Quantum theory can be used to give a more accurate and quantitative 
description of Raman effect. Perturbation theory can be used to explain Raman 
scattering [36]. This rather complicated theory can be simplified and explained 
through an energy level diagram (Figure 15). Raman scattering is a kind of inelastic 
scattering. Stokes Raman scattering arises when the final energy level is higher than 
the starting energy level. Anti-Stokes Raman scattering arises when the final energy 
level is lower than the starting energy level. According to Boltzmann’s population 
distribution:
■ ^ - = -^-exp(-A E /*T ) (3.11)
N v0 g v  0
where Nv/ and N„o are the populations of states vl and vO respectively, gv/ and gvo are 
the degeneracies of states vl and vO respectively, AE is the energy difference, k is


































Figure 15. Energy level diagram shows different scattering processes
EJ
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Boltzmann’s constant, and T is the temperature. Since Nvi is always smaller than Nvo 
at ambient temperatures, the Stokes Raman transition is more likely to occur than the 
anti-Stokes Raman transitions and hence the Stokes Raman lines are more intense 
than the corresponding anti-Stokes Raman lines.
The theoretical Raman intensity has been derived by Placzek [45]:
I = C [ hI°N (v° * ^  ](45or' 2 +7or' 2) (3.12)
m v( \ - e -hv,kT) s
where C is a constant, h is the Planck’s constant, 7o is the incident intensity, N  is the 
population of the excited energy level, vo is the incident frequency, v is the 
vibrational level frequency, m is the reduced mass of molecule, and« 'v and a'a are
the symmetric and asymmetric parts of the polarizability derivatives respectively. 
Equation 3.12 predicts that Raman intensity is directly proportional to the incident 
(laser) intensity, laser frequency to the fourth power, and the number of molecules 
excited. Therefore, Raman can be used as a quantitative tool. This equation can be 
expressed in a more practical way [45]:
7 = (70 -cr-K )-b -c  (3.13)
where K  is a constant related to the instrument, b is the pathlength in cm, c is the 
concentration in molecule per cm3, and a is the Raman cross section in cm2 per 
molecule. Because a is on the order of 10"28 for Raman compared to 10'17 for 
fluorescence, Raman is a rather weak phenomenon.
From Equation 3.12, the ratio of Stokes to anti-Stokes Raman intensity can be 
determined by the following relation:
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/ Stokes A E /k T (3.14)
I  an ti-S to kes  ( ^ 0  +  V )
which can be verified experimentally at thermal equilibrium.
The selection rule for Raman scattering is based on the Raman transition 
moment [13]:
where F, and Fj are the wavefunctions for states i and j ,  respectively, and dr indicates 
integration over all space. This relationship shows that there must be a change in 
polarizability for Raman scattering to occur. Furthermore, selection rules also 
predict that Raman can only be observed with transitions between states of Av = ±1 
for harmonic vibrations. Anharmonicity in real molecules allows much weaker 
overtones to be observed [13]. In contrast to IR spectroscopy, totally symmetric 
vibrations can often be observed in Raman. Furthermore, for molecules having a 
center of symmetry, vibrations cannot be both Raman and IR active; this is known as 
the mutual exclusion principle [13].
Chemometrics is a chemical discipline that uses mathematical, statistical and 
other methods employing formal logic to design or select optimal measurement 
procedures and experiments and to provide maximum relevant chemical information 
by analyzing chemical data [48]. The field of chemometrics seems to be a relatively
(3.15)
3.3 Background of Chemometrics
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new discipline of chemistry. Nevertheless, it actually has a very long history 
associated to it. Pioneers such as William S. Gossett and George E. P. Box had 
developed important statistical theories for chemical applications long before the 
term chemometrics was introduced and at times when computers were not popular 
[49, 50]. Gossett developed the famous Student’s t test to test for statistical 
significance [49]. Box was originally trained as a chemist and later became an expert 
in statistics. He had developed important theories and applications in the fields of 
quality control, time series analysis and design of experiments [50]. Computers were 
becoming more common in the late 1960s and early 1970s and chemists were able to 
more easily apply statistics and mathematics. Pioneers such as Svante Wold of 
Sweden, Bruce Kowalski of the United States, and D. L. Massart of Belgium started 
to develop chemometrics into a formal discipline in chemistry [48, 51-52].
Chemometrics generally involves four basic areas of study [53]. The first one 
is design of experiments. Well-developed methods such as factorial designs, central 
composite designs, and simplex designs can be used to optimize experimental 
parameters like the composition of mobile phases in HPLC. They can also be used 
to design the composition of calibration samples and screen the most significant 
factors in a chemical reaction.
The second area is signal processing. Methods such as the Savitsky-Golay 
filters and derivatives, Fourier filters and wavelet transforms are used to smooth a 
spectrum and improve the signal-to-noise ratio.
A third application is pattern recognition. Pattern recognition can be grouped 
into three major methods: exploratory data analysis (EDA), unsupervised pattern
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recognition (UPR), and supervised pattern recognition (SPR). The purpose of EDA 
is to determine general relationship between data. Principal component analysis 
(PC A) is the major method used in EDA. An example of EDA is the application in 
analysis of animal pheromones. EDA of chromatograms of animal urine samples can 
recognize differences in chromatograms of different groups or species and provide a 
simple picture as to the main relationships between the samples [53]. UPR is used to 
detect similarities in a data set. Cluster analysis is the major method used in UPR.
An example of cluster analysis is the evaluation of numerical taxonomy in biology. 
SPR is used to sample a number of groups; it is different from UPR as a training set 
of known groupings (predefined group) is necessary for SPR. Classifications of 
elements into the periodic table and grouping of organic compounds based on their 
functionalities are some examples of SPR [53].
The other chemometric application is calibration. Calibration is one of the 
most common practices in analytical chemistry. The simplest and most widely used 
form is classical univariate linear regression. This calibration technique simply 
relates two single variables to each other and forms a linear relationship. It often 
involves a constant term (intercept) to correct for baseline shifting. However, such 
univariate calibration methods may not give sensible models and predictions to the 
system under study and future samples when there is more than one component in 
the system. Multiple variables are needed to obtain a sensible model. Multiple 
linear regression (MLR) can be used in these situations. It is basically the same as 
classical univariate linear regression; the only difference is that it employs more than 
one variable to calculate the model. For example, three different wavelengths are
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used for a three-component mixture in a study using UV-vis spectroscopy. Note that 
the number of components in the mixture must be smaller than the number of 
variables or number of experiments in order to obtain a sensible model [53].
Unknown components such as interferents may be present in a chemical 
system. Such components may have significant influence to the system under study 
and hence perturb the data or spectra. Models generated by univariate methods and 
MLR are vulnerable to effects caused by these unknown components. Principal 
component regression (PCR) and partial least squares regression (PLS) can be 
applied in situations where not all significant components are recognized in a system. 
PCR is an inverse calibration method. Inverse calibration differs from classical 
calibration in that it formulates to predict the independent variable or concentration 
in most chemical applications directly [53].
PCR is based on the principles of principal component analysis (PCA). PCA 
is a data compression technique. It transforms the original data into principal 
components [53]:
X  = T'P + E  (3.16)
where X  is the original data (spectra) matrix, T is the scores matrix, P  is the loading 
matrix, and E  is the error matrix. The scores and loadings are abstract mathematical 
entities. The aim of PCR is to convert these abstract values into meaningful 
chemical information such as concentrations. The PCR equation is as follows [53]:
C = T R  + F  (3.17)
where C  is the concentration matrix, R  is the regression matrix containing the 
regression coefficients, and F  is an error matrix.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
58
PLS was introduced as a data analysis method in economics by Herman Wold 
[53]. It was formulated and applied to chemical problems by Svante Wold in the 
1970s and become one of the most popular methods in multivariate calibration [53]. 
PLS differs from PCR in that it models both the dependent and independent variables 
and hence it accounts for errors in both types of variables [53], as seen in Equations
3.18 and 3.19:
X  = T'P + E  (3.18)
c = T-q + f  (3.19)
where c is the concentration vector of one of the components, q is the regression 
vector analogous to the loading vector, an d /is  the error vector. Note that Equation
3.18 is identical to Equation 3.16; however, the algorithms for obtaining T  and P  are 
different.
3.4 Comparison of Quantitative Analysis of Active Pharmaceutical Ingredients 
by Traditional Methods and Raman Spectroscopy
Traditional methods such as wet chemistry methods and HPLC are being 
used for the determination and quantification of active pharmaceutical ingredients 
(API) in the pharmaceutical industry. Although they have been proven to be reliable 
for the determination of APIs, they suffer from certain disadvantages.
First, these methods are often time consuming. For example, the analysis of 
ibuprofen by acid-base titration takes at least an hour per sample [54]. Since time is 
one of the important factors in determining profit in the pharmaceutical industry,
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time-saving methods are preferred for these analyses. Second, traditional methods 
such as titration and gravimetric analysis often require extensive manual labor. Third, 
methods such as HPLC consume considerable volumes of organic solvent and 
chemicals which add to the cost of testing and manufacturing. Fourth, older methods 
such as titration usually suffer from low sensitivity. Fifth, sample preparation is 
usually intensive for these methods. Sometimes, the search for the proper solvent 
that will dissolve the sample and which is compatible to the method is time 
consuming. Finally, these methods are usually difficult or impossible to be adapted 
for on-production-line analysis. Again, offline analysis means extra time is 
necessary for testing and approval of products.
Although new techniques in mass spectrometry such as direct analysis in real 
time (DART) [55, 56] and desorption electrospray ionization (DESI) [57] show 
promise in fast analysis, Raman spectroscopy can provide advantages that are 
particularly suited to pharmaceutical analysis. For instance, sample preparation is 
minimal for Raman spectroscopy. No sample preparation is necessary in most 
situations. Samples can even be analyzed without being removed from the container 
when it is transparent to the excitation radiation. Skoulika and Georgiou [58] applied 
FT Raman spectroscopy to quantify acyclovir in pharmaceutical dosage forms 
through their poly(vinyl chloride) blister packages. Furthermore, solid samples can 
be readily analyzed by Raman spectroscopy without dissolution of the sample. This 
is particularly advantageous to pharmaceutical analysis because most APIs are in the 
solid-state form. In addition, sampling is nondestructive in Raman spectroscopy.
That means samples can always be reanalyzed. Since Raman spectroscopy employs
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a laser as its excitation source, the sampling volume can be lowered to within a few 
microns by focusing the laser beam using a high numerical aperture microscope 
objective. Fast analysis time can be achieved with Raman spectroscopy, especially 
for FT instruments. It only takes a few seconds for a full spectral scan (4000 cm'1) in 
these types of instruments. Compared to other spectroscopic techniques such as UV- 
vis and IR spectroscopies, overlapping bands are less common with Raman 
spectroscopy. Since sample preparation is not necessary in most situations, Raman 
spectroscopy combined with advanced chemometric data analysis can definitely be 
applied as an online analytical method for pharmaceutical analysis. Although normal 
Raman spectroscopy is not very sensitive, it is adequate in most pharmaceutical 
applications. Furthermore, sensitivity can be enhanced greatly by applying 
resonance Raman spectroscopy.
3.5 Research Direction
Over-the-counter (OTC) cold medications are some of the most common 
pharmaceutical compounds. Cold medicines for multiple symptoms may consist of 
an analgesic, a cough medicine, and a nasal decongestant. Acetaminophen (Figure 
16a) is a common analgesic for pain and fever relief. Guaifenesin (Figure 16b) is an 
expectorant for cough relief. Phenylephrine hydrochloride (Figure 16c) is a nasal 
decongestant to treat nasal discomfort. The latter is a substitution for 
pseudoephedrine, a nasal decongestant which can be used as a precursor for the
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Figure 16. Structures of active pharmaceutical ingredients, (a) Acetaminophen, (b) 
guaifenesin, (c) phenylephrine hydrochloride.
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synthesis of methamphetamine. The Combat Methamphetamine Epidemic Act of 
2005 limits the sale of pseudoephedrine [59].
Quantitative analyses of multiple pharmaceutical components have often 
been performed using separation techniques such as HPLC, capillary electrophoresis, 
and micellar electrokinetic chromatography [60-62], However, these techniques 
suffer from some of the drawbacks mentioned in Section 3.4. Currently, the 
application of spectroscopic methods combined with chemometrics offers alternative 
methods for the quantitative determination of APIs without separation [5, 63-64], 
These methods show promise for online analyses in pharmaceutical plants.
The goal of this research project is to investigate the application of dispersive 
Raman spectroscopy combined with multivariate calibration for the simultaneous 
determination and analysis of three active pharmaceutical ingredients 
(acetaminophen, guaifenesin, and phenylephrine hydrochloride) in an OTC cold 
tablet.
3.6 Experimental Setup and Instrumentation
3.6.1 Design o f  Experiments
The experimental design was based on the content of the active 
pharmaceutical ingredients present in the OTC drug. The labeled amounts of 
acetaminophen, guaifenesin, and phenylephrine hydrochloride are 325 mg, 200 mg, 
and 5 mg, respectively. These correspond to 43.0 % of acetaminophen, 26.5 % of
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guaifenesin, and 0.7 % of phenylephrine hydrochloride in each tablet by weight. The 
first step of the experimental design was to define the range of each active ingredient 
for the calibration set. The only prerequisite was to include the aforementioned 
concentration in each range. The ranges for acetaminophen, guaifenesin, and 
phenylephrine hydrochloride were 30-55 %, 15-40 %, and 0.1-10 %, respectively.
The second step was to decide the number of calibration samples. There are 
no rules as to how many calibration samples one should use. Generally, the more the 
components in a system, the more calibration samples should be used. Furthermore, 
more calibration samples would usually minimize the prediction error and enhance 
the predictive model. Obviously, more time and money will be needed for sample 
preparation and analysis if more samples are used. Hence there is a trade-off and the 
final decision often depends on factors such as the system under investigation, 
needed accuracy level, time required for the study, and financial issues. Twenty-five 
calibration samples were used in this study.
The third step was to determine the distribution of concentrations of the 
samples. The criterion of this step was to ensure there are no correlations between 
any components. This is important because one can only determine the 
concentrations independently among the components in the system if the 
concentrations of each component are uncorrelated to each other [53]. There are 
many well-established ways to achieve this condition in a calibration set such as 
factorial and central composite designs [53]. In this study, the concentrations were 
generated simply using the RAND function of the Microsoft Excel software with the 
constraints of the concentration ranges (Table 5). The correlation among the
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0.5070 0.2722 0.0231 0.1977
0.4972 0.1770 0.0626 0.2637
0.4647 0.2930 0.0126 0.2297
0.4558 0.2812 0.0635 0.1994
0.5037 0.3375 0.0059 0.1529
0.4344 0.3381 0.0751 0.1523
0.3025 0.3274 0.0620 0.3080
0.3915 0.3459 0.0789 0.1837
0.4401 0.3625 0.0423 0.1551
0.4324 0.2769 0.0311 0.2597
0.5380 0.2427 0.0193 0.2000
0.3410 0.3526 0.0843 0.2222
0.4327 0.3783 0.0709 0.1181
0.4669 0.2239 0.0924 0.2168
0.4046 0.2741 0.0757 0.2456
0.4888 0.3171 0.0449 0.1492
0.5303 0.2701 0.0669 0.1326
0.4505 0.2265 0.0196 0.3035
0.5503 0.2593 0.0631 0.1273
0.3749 0.3862 0.0609 0.1780
0.5120 0.2147 0.0383 0.2350
0.3254 0.3561 0.0805 0.2380
0.3525 0.2802 0.0236 0.3436
0.5235 0.2889 0.0299 0.1576
0.4870 0.2884 0.0381 0.1866
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components can be checked by two methods. The first one is to calculate the 
correlation coefficients. They should be close to zero. The second method is to plot 
the concentrations of each component versus the concentrations of each of the other 
components and examine the plots (Figure 17). The low R values indicate little 
correlation between any two components.
3.6.2 Sample Preparation
Solid samples were used in this study. Calibration samples were prepared by 
grinding and mixing the appropriate amounts of the active ingredients (Sigma- 
Aldrich, Milwaukee, WI) with potassium ferricyanide (Mallinckrodt, Hazelwood, 
MO) which was used as a diluent and internal standard. An alumina mortar and 
pestle (CoorsTek, Golden, CO) was used for grinding and mixing. The compounds 
were ground and mixed thoroughly using mortar and pestle for at least 15 minutes to 
ensure homogeneity. Two tablets of the OTC drug were weighed and ground into 
fine powders. An 89 % OTC sample was prepared by mixing a powdered OTC 
medication with an appropriate amount of potassium ferricyanide. Fourteen kinds of 
excipients were listed on the label of the OTC drug. Only seven of these were 
examined because some compounds were unavailable commercially or the exact 
form of the listed compound was not certain. The excipients analyzed were titanium 
dioxide, povidone, talc, silica gel, com starch, microcrystalline cellulose, and 
magnesium stearate (Sigma Aldrich, Milwaukee, WI). All samples were pressed into
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Figure 17. Concentration versus concentration plots.
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pellets by an IR press (Wilks Scientific, South Norwalk, CT) to ensure a flat surface 
for Raman analyses.
3.6.3 Raman Spectroscopy
Raman spectroscopy was performed using a Renishaw Raman imaging 
spectrometer model S2000 (Renishaw, Gloucestershire, UK). This model employs a 
dispersive optical system with an 1800/mm holographic diffraction grating as the 
wavelength selector. The focal length of the grating monochromator is 0.25 m and 
the reciprocal linear dispersion is 2.2 nm/mm. The slits were set at 100 microns and 
hence the spectral resolution was about 5 cm'1. The excitation source is a 632.8 nm 
HeNe laser operating in a continuous mode with an optical power output of about 30 
mW. The laser was focused to the sample by a 5x objective, and focusing was done 
by observing the microscopic image with a white light source. The focused laser
'y
spot size was about 0.5 mm . Although higher power objectives (20x and 50x) 
enhanced the signal, they were not used because the laser spot sizes generated by 
these objectives were too small. More spectra are needed using small spot sizes and 
inhomogeneity of samples may create problems for quantitative analysis if too few 
spectra are used. One hundred eighty degrees back-scattering geometry was utilized 
for the collection of Raman scattering. A pair of holographic notch filters was used 
for Rayleigh scattering rejection. A charge-coupled device was used for detection. 
The spectral range of acquisition was 100 to 4000 cm'1. It required about 90 s for the
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collection of each spectrum. Ten and fifty spectra were collected for each calibration 
sample and OTC sample, respectively. Two and four pellets were used for each 
calibration sample and OTC sample, respectively. Five spectra were collected for 
each excipient sample. One pellet was used for each excipient sample. Each 
spectrum was obtained at a different location of the sample pellet to compensate for 
any inhomogeneity of the sample. All Raman spectra were collected through 
computer interface using the GRAMS/32 software (Thermo Fisher Scientific, 
Waltham, MA). A summary of the Raman experimental setup can be found in Table 
6.
3.7 Data Analysis
Data analysis was performed using GRAMS/32, Microsoft Excel (Microsoft, 
Redmond, WA), and MATLAB (Mathworks, Natick, MA). GRAMS/32 was used 
mainly for initial processing of the spectra such as co-adding, baseline corrections 
and normalizations. Excel was used mainly for error calculations and graph 
production. MATLAB was used as the major tool for multivariate calibrations. 
Multivariate calibrations were performed by the partial least squares regression 
method and the algorithm used was PLS1 [53]. The theory of PLS was described in 
Section 3.3. All spectra were mean-centered prior to the PLS analysis. Calibration 
models were validated by leave-one-out cross-validation [53]. A sample was left out 
as the test sample and the rest of the calibration set was used for establishing the
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Table 6. Raman experimental conditions
Laser wavelength 632.8 nm
Laser power -30 mW
Focused laser beam size -0.5 mm2
Lasing mode Continuous
Spectral resolution -5  cm'1
Focusing objective 5x
Collection geometry 180° back-scattering
Detector CCD
Acquisition range 100-4000 cm'1
Averaging 5 - 5 0  spectra
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model. This process repeats until every sample was used once as a test sample. All 
algorithms were implemented as MATLAB programs.
Different preprocessing methods were examined to determine the best 
method to be used in determining the concentration of active ingredients in the OTC 
drug. The preprocessing methods examined in this study were linear and polynomial 
baseline correction, first and second derivatives, pseudosecond derivative (PSD), 
normalization by an internal standard and partial spectrum, multiplicative signal 
correction (MSC) and standard normal variate (SNV) transformation.
Linear and polynomial baseline corrections were performed using 
GRAMS/32 software. A five-point cubic function set at 3400, 2800, 1700, 900, and 
200 cm'1 was used initially to correct for the baseline. Linear baseline correction was 
applied at 11 spectral points (3900, 3450, 2795, 1760, 1540, 1200, 1085, 897, 562, 
292, and 139 cm'1) after the cubic baseline correction.
Derivatives can be used to enhance the resolution of a spectrum because the 
inflection points between close peaks become turning points in derivatives [53]. It is 
more common to use derivatives for baseline correction in Raman spectroscopy 
because fluorescence and other instrumental fluctuations may cause baseline shifts. 
Derivatives can amplify the noise in the spectrum and hence degrade the signal-to- 
noise ratio. This problem can be overcome by using Savitsky-Golay (SG) smoothing. 
In this study, a seven-point second-order SG polynomial was used for both first and 
second derivatives calculations. All derivatives calculations were performed by 
GRAMS/32 software.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
71
Subtracted shifted baseline correction (SSBC) is a baseline correction method 
introduced by P. A. Mosier-Boss et al. [65] and further developed and applied by S. 
E. J. Bell et al. [66, 67]. It is an alternative method to shift excitation Raman 
difference spectroscopy (SERDS), where a tunable laser source is needed for shifting 
the laser excitation wavelength. The combination of SSBC and first derivative is a 
baseline correction method called pseudosecond derivative [68]. This method can 
eliminate any fixed-pattem noise generated by the CCD detector and correct for the 
baseline shift caused by fluorescence similar to the conventional second derivative 
method. However, this method has an advantage over the conventional second 
derivative method- the signal-to-noise ratio is higher [68]. There are two ways to 
shift a spectrum [65]. One is to obtain a spectrum with the grating held at one 
position. Then a second spectrum is obtained by shifting the grating by a small (6) 
wavenumber. The shifted spectrum is obtained by subtracting the second spectrum 
from the first spectrum. Another way is to shift a spectrum mathematically using a 
computer and subtract the resultant spectrum from the original spectrum. In this 
study, the second method was used to shift the spectra and 6 was set at 10 cm'1 [68]. 
First derivatives were taken on the shifted spectra with seven-point second-order SG 
polynomial smoothing. All PSD calculations were performed by GRAMS/32 
software.
Normalization is commonly employed to correct for instrumental fluctuations 
and sampling deviations in spectroscopic applications. Normalization can be 
performed by subtracting or dividing the spectrum by a constant. In this study, two 
types of normalization constant were examined. The integrated peak area (2100 -
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2160 cm'1) of potassium ferricyanide was used as the constant for the first type. The 
integrated area of the partial spectrum (300-1750 cm'1) was used as the constant for 
the second type. All normalization calculations were performed by GRAMS/32 
software.
Multiplicative signal correction is also termed multiplicative scatter 
correction because it was first developed and applied for the correction of scattering 
effects caused by physical differences in samples in near-infrared (NIR) 
spectroscopy [69]. It has been successfully applied in quantitative analysis of Raman 
spectroscopy for the correction of some sampling problems [70]. This method 
corrects the additive and multiplicative effects of each spectrum by first regressing it 
against the average spectrum through the least-squares algorithm:
xt = a, + b (x + et (3.20)
where x is the original spectrum for sample i, x is the average spectrum, and e is the 
residual spectrum. The MSC corrected spectrum is generated by subtracting the a 
coefficient and dividing by the b coefficient:
(3-21)
b
All MSC calculations were performed by Excel software.
The purpose of standard normal variate transformation is the same as MSC.
It was developed and applied in NIR diffuse reflectance spectroscopy to correct for 
unwanted scattering effects and variable sample pathlengths [71]. SNV 
transformation was applied successfully in quantitative Raman spectroscopy [72].
The SNV transformed spectrum is obtained by first subtracting the average spectral
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where n is the number of spectral values. All SNV calculations were performed by 
Excel software.
Untreated (except for co-adding) spectra were also used in multivariate 
calibration to compare with the results of the preprocessing methods. A summary of 
preprocessing methods and the descriptions of these methods examined in this study 
can be found in Table 7.
3.8 Examination of Raman Spectra
Raman spectra of the three active pharmaceutical ingredients and the OTC 
drug are shown in Figure 18. Examination of the API spectra revealed a number of 
overlapping bands. Hence, multivariate calibration should be used for the 
quantification of these three APIs. Most Raman bands reside between 300 and 1750 
cm'1. Therefore, this spectral region was used for calibration. Examination of the 
OTC drug spectra revealed that all visible peak positions were in good agreement 
with the peak positions of the API spectra. However, there is a large baseline shift 
which is caused by the fluorescence of the excipients contained in the drug.
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Table 7. Summary of preprocessing methods
Method number Method description
1 Raw data without any preprocessing
2 Linear and cubic baseline correction combined with 
normalization using the integrated area of the potassium 
ferricyanide peaks
3 Linear and cubic baseline correction combined with 
normalization using the integrated spectral area 3 0 0 - 1750 
cm'1
4 Linear and cubic baseline correction combined with 
multiplicative signal correction
5 Linear and cubic baseline correction combined with standard 
normal variate transformation
6 First derivative combined with standard normal variate 
transformation
7 Second derivative combined with standard normal variate 
transformation
8 Pseudosecond derivative combined with standard normal 
variate transformation
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Figure 18. Raman spectra of APIs and OTC drug. From top to bottom: OTC drug, 
guaifenesin, phenylephrine hydrochloride, and acetaminophen (spectra are offset for 
clarity).
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Raman spectra of the seven excipients are shown in Figure 19. All spectra 
exhibit some fluorescence background for the spectral region examined except for 
titanium dioxide. Among them, microcrystalline cellulose exhibits the strongest 
fluorescence background. Although there is no fluorescence background for the 
titanium dioxide spectrum, there are three very strong Raman peaks at 395.4, 514.5, 
and 638.1 cm'1. However, these peaks cannot be found in the OTC drug spectrum. 
This reveals that the amount of titanium dioxide in the OTC drug is very low. All 
other excipient spectra exhibit weak or no Raman features; therefore, these 
excipients were not included in the calibration samples.
3.9 Selection of Internal Standard
An internal standard is often used in quantitative Raman spectroscopy [73] as 
a method to correct or compensate for the instrumental fluctuation and sampling 
variability. There are several criteria for choosing a suitable internal standard for 
Raman spectroscopy. First, the internal standard should not interact chemically with 
other components in the sample. Second, it should not interfere spectrally with other 
components. Third, the intensity of the Raman feature should be similar to that of 
other components so that they can be collected using the same instrumental settings. 
Fourth, no or minimal fluorescence should be exhibited with the excitation 
wavelength applied. Potassium ferricyanide was chosen as the internal standard for 
this study because it met all these criteria. Two strong peaks centered at 2130 cm'1 
that are free of other spectral features were used for normalization (Figure 20).
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Figure 19. Raman spectra of excipients. From top to bottom: Microcrystalline 
cellulose, magnesium stearate, povidone, silica gel, com starch, talc, and titanium 
dioxide.
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Figure 20. Raman spectra of potassium ferricyanide (bottom trace) versus active 
pharmaceutical ingredients and OTC drug.
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3.10 Statistical Tools for Model Evaluations
In order to assign the number of PLS components and validate each model, 
cross-validation was used and the relative root mean square error of prediction 
(RRMSEP) was calculated for each PLS component of each model [53]:
where y  is the average of the real concentration, y  is the predicted concentration by 
cross-validation, and m is the number of samples. All concentrations were expressed 
as the mass percentage of the component relative to the total mass except for the 
model using potassium ferricyanide for normalization where they were expressed as 
the mass ratio between the component and potassium ferricyanide. The number of 
PLS components used for each model was determined by the lowest RRMSEP in 
most cases. In other cases, it was determined as the RRMSEP starts to become 
constant. Correlation coefficients (CC) were also calculated to determine the 
goodness of fit of the models [53]:
RRMSEP (3.23)
m
I > ,  -y)(y, -y)
cc = (3.24)
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where y  is the average of the predicted concentrations. CC values close to 1 
indicate better correlations. The variance explained by each model is related to the 




where t and p  are the score and loading components of the PLS model respectively, a 
is the PLS component, m is the number of samples, and n is the number of spectral 
values. It is a common practice to express the variance (V) in terms of the 
cumulative fraction of the PLS component magnitude [53]:
A
V = ~— ------  (3.26)
m n N 7
z z v(=1 7=1
where A is the number of PLS components used in the model and x are the spectral 
values. Higher values of V means more variance is explained by the model.
3.11 Analysis of Acetaminophen
The RRMSEP were plotted against the number of PLS components for each 
preprocessing method (Figure 21). The RRMSEP, number of PLS components, 
correlation coefficients, and the variance fraction for each method are summarized in 
Table 8. The combination of PSD and SNV (Method 8) gave the best prediction 
results in terms of RRMSEP. The use of the integrated peak area of potassium 
ferricyanide as the normalization constant (Method 2) gave the worst prediction
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1 0.106 3 0.992 0.73
2 0.215 4 0.999 0.82
3 0.088 4 0.981 0.82
4 0.086 4 0.961 0.83
5 0.086 4 0.960 0.83
6 0.077 4 0.970 0.86
7 0.100 4 0.909 0.76
8 0.071 4 0.968 0.89
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results in terms of RRMSEP. A probable cause of the high error associated with this 
method is the inhomogeneity of the sample mixtures, especially for the potassium 
ferricyanide component. This inhomogeneity problem may arise from the nature of 
potassium ferricyanide. Since potassium ferricyanide appears as crystals, it was 
difficult to homogenize completely with the powdered acetaminophen. Despite the 
high variance fraction, the low correlation coefficient of this model is another 
indicator that this was not a good normalization method. In fact, the extra variance 
may have originated from sample inhomogeneity and spectral noise.
All methods required four PLS components to account for the model except 
for the model acquired with raw data (Method 1). This number was obtained based 
on the lowest RRMSEP among the PLS components. However, Figure 18a shows 
that RRMSEP increased sharply when seven PLS components were used and it 
decreased again when more PLS components were used. This unusual behavior of 
the error distribution may be partly caused by baseline variation. Results of MSC 
(Method 4) and SNV (Method 5) were very similar to each other. This was due to 
the fundamental properties of these two methods, both techniques used to correct for 
unwanted multiplicative and additive effects. Results of second derivatives (Method 
7) were worse than those of first derivatives (Method 6) (Figure 21). This was due to 
the signal-to-noise ratios of second derivative spectra being lower than those of first 
derivative spectra.
Comparing the results of PSD and first derivatives, PSD was the better 
method for fluorescence and baseline corrections. The better signal-to-noise ratio of 
PSD spectra was one of the factors for such improvement. Although the use of
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partial spectra for normalization (Method 3) gave better results than the use of 
potassium ferricyanide, the results were still somewhat worse than those of MSC and 
SNV. In summary, the use of PSD in addition to SNV for baseline and sampling 
variation corrections gave the most satisfactory results for the calibration of 
acetaminophen.
3.12 Analysis of Guaifenesin
The RRMSEP were plotted against the number of PLS components for each 
preprocessing method (Figure 22). The RRMSEP, number of PLS components, 
correlation coefficients, and the variance fraction for each method are summarized in 
Table 9. The results for guaifenesin were similar to those for acetaminophen. The 
use of potassium ferricyanide for normalization produced the highest RRMSEP again 
for the determination of guaifenesin. Although the RRMSEP of the raw data was 
comparable to other methods (except for Method 2), MSC and SNV results required 
fewer PLS components for modeling. This shows that MSC and SNV removed some 
unwanted instrumental and sampling variations. More PLS components were also 
needed for the derivatives models, especially for the second derivative model. This 
may be due to increasing variation of the spectra. Similar to the results of 
acetaminophen, PSD combined with SNV produced the lowest RRMSEP and the 
RRMSEP was comparable to the RRMSEP obtained from the same method for 
acetaminophen.

























o . 0-27 
£  0.25





1214 0 2 4 6 8 10 14
PLS component PLS component

























j e  0.095 










14 0 2 4 6 8 10 12 14





£  0.13 
^  0.125 












140 2 4 6 8 10 12 0 2 6 8 104 12 14
PLS component PLS component
Figure 22. RRMSEP versus PLS components for guaifenesin. Plots a to h: Method 1 
to 8, respectively.
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1 0.083 6 0.998 0.90
2 0.188 4 0.999 0.87
3 0.078 4 0.979 0.90
4 0.082 3 0.937 0.89
5 0.081 3 0.936 0.90
6 0.076 4 0.972 0.91
7 0.104 6 0.923 0.82
8 0.074 4 0.976 0.91
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3.13 Analysis of Phenylephrine Hydrochloride
The RRMSEP were plotted against the number of PLS components for each 
preprocessing method (Figure 23). The RRMSEP, number of PLS components, 
correlation coefficients, and the variance fraction for each method are summarized in 
Table 10. The RRMSEP were higher than those obtained for the other two APIs by 
approximately a factor of three. This was due to the low concentrations of 
phenylephrine hydrochloride and hence much lower signal-to-noise ratio of the 
Raman peaks. Unlike the other two APIs, the RRMSEP of Method 2 was 
comparable to those obtained by other preprocessing methods. This shows that the 
low signal-to-noise ratio was the dominant factor for the high RRMSEP rather than 
the inhomogeneity of potassium ferricyanide. Similar to the results of the other two 
APIs, PSD combined with SNV generated the lowest prediction error and effectively 
removed some variations due to the instrument and sampling processes.
3.14 Analysis of the Over-the-Counter Pharmaceutical Product
Statistical analyses of the models generated using different preprocessing 
methods in the previous sections revealed that the best method for quantification of 
APIs was the combination of PSD and SNV transformation (Method 8). Therefore, 
the PLS model generated by this preprocessing procedure was used to determine the 
concentrations of the APIs in the OTC pharmaceutical product. Triplicate analyses 
were performed to obtain standard deviations. The results of the analysis are
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Figure 23. RRMSEP versus PLS components for phenylephrine hydrochloride. Plots 
a to h: Method 1 to 8, respectively.
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1 0.322 8 1.000 0.79
2 0.235 5 1.000 0.92
3 0.301 4 0.981 0.79
4 0.261 3 0.943 0.84
5 0.259 3 0.942 0.85
6 0.222 3 0.967 0.89
7 0.240 3 0.905 0.88
8 0.221 3 0.969 0.89
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summarized in Table 11. The predicted concentrations in the OTC drug were 46.3 ± 
0.5 %, 27.8 ± 0.4 % and 1.0 ± 0.1 % for acetaminophen, guaifenesin, and 
phenylephrine hydrochloride, respectively. The low standard deviation values 
indicate good precision can be obtained by the calibration models. Although the 
relative percentage difference was high for phenylephrine hydrochloride, the 
absolute difference with respect to the labeled concentration was only 0.3 %, which 
was acceptable.
3.15 Summary and Future Directions
This research demonstrates the quantification of acetaminophen, guaifenesin, 
and phenylephrine hydrochloride using dispersive Raman spectroscopy and 
multivariate calibration. The application of this method to the quantification of these 
three active pharmaceutical ingredients in an over-the-counter drug was also 
demonstrated.
Pseudosecond derivatives and standard normal variate transformation were 
the most suitable preprocessing methods in this study. The relative root mean square 
errors of prediction were 7.1 %, 7.4 %, and 22.1 % for the determination of 
acetaminophen, guaifenesin, and phenylephrine hydrochloride respectively. The 
predicted concentrations were 46.3 ± 0.5 %, 27.8 ± 0.4 % and 1.0 ± 0.1 % for 
acetaminophen, guaifenesin, and phenylephrine hydrochloride respectively in the 
OTC drug.
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Acetaminophen 43% 46.3 % 0.5 7.7 3.3
Guaifenesin 26.5 % 27.8 % 0.4 5.1 1.3
Phenylephrine
hydrochloride
0.7 % 1.0% 0.1 46.6 0.3
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Although thorough mixing was performed in sample preparations, sample 
inhomogeneity was still one of the major factors associated with calibration and 
prediction errors. One possible solution for this problem is to improve sampling 
technique. For instance, a rotating sample holder can be used so that a larger sample 
area can be examined in shorter time periods. Alternatively, a larger laser spot size 
can be used for excitation and Raman scattering collection. Prediction error 
associated with the predicted concentrations of APIs in the OTC drug may be 
lowered by using the specified amounts of excipients that were present in the drug as 
diluents in the calibration sample set.
For future directions, Raman spectral imaging can be applied in addition to 
Raman spectroscopy for quantification of pharmaceutical products. More spectral 
information may enhance the predictability of the models. Pharmaceutical products 
with other active components may also be examined by such methodology. Online 
real-time Raman detection of pharmaceutical ingredients is possible with additional 
hardware and computing controls.
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CHAPTER 4
DEVELOPMENT OF AN ULTRA-VIOLET ACOUSTO-OPTIC TUNABLE-
FILTER RAMAN SPECTROMETER FOR PHARMACEUTICAL
APPLICATIONS
4.1 Introduction
The previous chapter discussed the application of Raman spectroscopy and 
chemometrics for quantitative pharmaceutical analysis. Although Raman 
spectroscopy is an excellent technique for such analyses, Raman instruments are 
traditionally stationary and bulky. For reasons of flexibility and convenience, more 
portable and lighter instruments are advantageous in an industrial setting such as the 
pharmaceutical industry. A portable instrument could be used at different 
manufacturing locations and even outdoors for applications such as testing of a 
defective sample on site. This can be done more conveniently and easily with 
smaller instruments. Therefore, the development of a portable Raman spectrometer 
that is smaller, lighter, faster, and energy efficient has potential value for 
pharmaceutical analysis.
This chapter documents the development of an ultra-violet (UV) acousto- 
optic tunable-filter (AOTF) Raman spectrometer. The evaluation of feasibility for 
this instrument is discussed. The first section of this chapter gives a brief
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background on AOTFs. The second part describes research that has been performed 
using AOTF for Raman spectroscopy and the goals and focus of this research. The 
third part presents the experiments and discussion of the generated results. The final 
page contains conclusions and future outlooks.
4.2 Background of Acousto-Optic Tunable-Filters
The first part of this section describes the theory of collinear AOTFs. The 
operation of an AOTF is based on the anisotropic Bragg diffraction of light by 
acoustic waves [74]. The condition of Bragg diffraction is determined by the 
Raman-Nath parameter Q:
Q = 4LX/A2 (4.1)
where L is the interaction length between the light and acoustic waves, X is the 
optical wavelength, and A is the acoustic wavelength. The diffraction is said to be in 
the Bragg region when Q »  1 [74].
The essence of this diffraction can be illustrated by a simple classical wave 
vector diagram for the collinear case (Figure 24) [74], In this diagram, kj, k<j, and K 
represent the wave vectors of the incident wave, diffracted wave and acoustic wave 
respectively. The magnitudes of these vectors are related to the refractive indices:
2^  2^  2^ = 2^ /
K  A> A v
where rij and rid are the refractive indices of the incident and diffracted waves 
respectively, X0 is the diffracted wavelength, / i s  the acoustic frequency, and Fis the
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Optic axis
Figure 24. Wave vector diagram for a collinear AOTF. Noncollinear AO interaction 
is denoted by vectors with prime symbols.
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acoustic velocity [74]. The law of conservation of momentum states that the total 
incident momentum must equal the total diffracted momentum:
h( ki ± K) = hka (4.3)
where h is Planck’s constant. The momentum-matching condition is satisfied when 
the tangential planes at the wave front surface of the kj and kd vectors are parallel [74] 
(dotted lines in Figure 24). For small angular deviations, this condition is still 
approximately held [74] (Figure 24). This is important for the applications of AOTF 
because this means the incident light does not need to be perfectly collimated.
Inserting Equation 4.3 into Equation 4.2, a relationship between the acoustic 
frequency and the diffracted wavelength can be obtained:
A = V(-n‘ ±nl> (4.4)
/
This is the basic tuning equation for collinear AOTFs. The difference between the 
refractive indices is usually used to avoid the frequency becoming too high for 
practical purposes. For instance, the refractive indices of quartz are 1.5534 and 
1.5443 and the acoustic velocity is 5960 m/s. If the diffracted wavelength is 250 nm, 
the tuning frequency would be 217 MHz using the difference between the refractive 
indices rather than 74 GHz using the sum of the indices. The resolution of the 
collinear AOTF can be calculated by [74]
0<Mi (4.5)
This expression shows that the resolution of the collinear AOTF can be maximized 
by increasing the interaction length. However, this leads to the decrease of the
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angular aperture (36,) because [74]
< « , = [ , 09/1 r  (4-6)
(nd -n ,)L
Nevertheless, the limiting factor of the interaction length is acoustic attenuation 
rather than the availability of the AO medium [74].
For AOTF devices, only the first-order (+1 or -1) diffraction is strong while 
all the other orders are very weak. This arises because only the first-order diffraction 
can satisfy the phase-matching condition (kj ± K - k j = Ak = 0) based on the phase- 
mismatch factor:
sin(M wZ/2) 2 
(AkmL /2)
the long interaction length of AOTF, and the inherent properties of AO interactions 
[74], This is the consequence of Bragg diffraction and advantageous to the 
applications in Raman spectroscopy.
The AOTF efficiency (E) can be determined by
E = rjAAQR (4.8)
where rj is the diffraction efficiency of the AO medium, A is the optical aperture, AQ 
is the solid acceptance angle, and R is the resolving power [74]. This expression can 
be written alternatively as
(4.9)
2A H
where M2 is the acousto-optic figure of merit, Pa is the acoustic power, and H  is the 
height of the AO medium [74], This expression assumes that the diffraction
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efficiency is not too large and the refractive indices are independent of the diffracted 
wavelength [74]. The acousto-optic figure of merit (Mi) is only dependent on the 
properties of the AO medium:
m 2 = ( 410)
2 p V 3
where p  is the effective acousto-optic coefficient and p is the density of the AO 
medium [74]. Equation 4.9 shows that the filter efficiency can be enhanced by 
increasing the interaction length, optical aperture, and acoustic power and by 
decreasing the height of the AO crystal. Also, the filter efficiency is better at shorter 
wavelengths. This characteristic is advantageous to applications in the UV region of 
the electromagnetic spectrum.
The operation of a collinear AOTF is depicted in Figure 25 [75]. A radio 
frequency signal is directed into the piezoelectric transducer and acoustic wave is 
generated inside the transducer. This longitudinal wave is converted into a shear 
wave after reflection off the AO crystal face. This shear wave propagates with the 
input optical wave collinearly and AO interaction occurs. This interaction causes 
diffraction of light. The undiffracted light and the diffracted light depart the AOTF 
collinearly. Since the diffracted light is orthogonally polarized with respect to the 
incident light, it can be separated by a polarizer [75].
The first collinear AOTF was described by Harris and Wallace in 1969 [76], 
However, research concerning the use of AOTF in spectroscopy has been the most 
active in the last two decades. For example, Treado and coworkers applied an AOTF 
for near-infrared imaging of biological samples [77], Alexander et al. used an AOTF
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Figure 25. Operation of a collinear AOTF (adapted from [75]).
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for fluorescence spectroscopy of chlorophylls a and b [78]. Gillespie and Carnahan 
utilized an AOTF for atomic spectroscopy in the UV region [79]. Gupta and 
Yoloshinov developed an UV AOTF based on a KDP crystal for hyperspectral 
imaging [80].
4.3 Research Direction
Although AOTF is becoming more popular for applications in spectroscopy, 
there are relatively few literature citations on the application of AOTFs for Raman 
spectroscopy. For those that were reported, a visible source was used. For instance, 
Lewis et al. [81] reported using a tellurium dioxide (Te02) AOTF and a 647 nm 
krypton ion laser for Raman spectroscopy. Gupta and Fell [82] applied a collinear 
quartz AOTF and an argon ion laser operating at 514.45 nm for Raman spectroscopy 
of organic compounds. Chen and coworkers [83] developed a portable Raman 
integrated tunable sensor utilizing a Te02 AOTF for wavelength selection, an 830 
nm diode laser for excitation, and an avalanche photodiode for detection.
The goal of the project described in this chapter is to investigate the use of 
UV AOTFs and compact deep-UV lasers to construct a miniature Raman 
spectrometer for pharmaceutical and other field applications. There are a few 
potential advantages of this spectrometer. First, it may be made very small because 
of the smaller size of the AOTF and laser compared to that of a grating 
monochromator and conventional lasers such as the neodymi um: yttrium-aluminum- 
gamet (Nd:YAG) laser. Second, very fast continuous scanning and discrete
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wavelength access are possible because of the fast transit time of acoustic waves in 
AOTF. A 4000 cm'1 spectrum with 12 cm'1 resolution can be obtained within one 
millisecond [79]. Third, the sensitivity may be improved in the deep UV region 
because the Raman intensity is directly proportional to the fourth power of the 
excitation frequency (Equation 3.12). Fourth, optical throughput can be enhanced 
because of the much larger optical aperture of AOTF compared to that of a grating 
monochromator. Fifth, higher AOTF spectral resolution can be obtained in the UV 
region because the resolution of the AOTF is directly proportional to the square of 
the diffracted wavelength (Equation 4.5). Sixth, the power consumption of the 
instrument can be reduced because the power of the AOTF can be gated on or off 
with the use of a pulsed laser. Therefore, cooling of the AOTF may not be necessary 
and power usage can be significantly reduced. Finally, the effects of background 
fluorescence can be minimized or eliminated by operating in the deep UV region.
4.4 Visible Raman Spectroscopy with Double Monochromators
As mentioned in Chapter 3, the Raman effect is an extremely weak 
phenomenon. It is a very difficult and time-consuming task to align and optimize the 
system with a UV excitation source since it cannot be seen by human eyes.
Therefore, a visible excitation source was first used to configure the optical and 
electronic components and obtain Raman spectra of some strong Raman scatterers.
In this section, a visible Raman spectrometer, Raman spectra obtained by this 
spectrometer, and some aspects of these preliminary experiments are presented.
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4.4.1 Experimental Setup
A schematic diagram of the Raman spectrometer is shown in Figure 26. A 
solid-state Nd:YAG laser (Continuum, Santa Clara, CA) operating at 532 nm (second 
harmonic) was used. The laser power was detuned to 19 mW to avoid laser-induced 
breakdown of a focused beam in air. The pulse frequency was 10 Hz and the pulse 
width was about 6 ns. The spectral line width was about 1.0 cm'1. The output laser 
beam was further filtered and turned 90° by a pair of dichroic mirrors (Continuum, 
Santa Clara, CA). The laser beam was then expanded to about 2 cm in diameter by a 
concave and a convex lens in order to spread the energy into a larger area and reduce 
the energy density attained by the laser bandpass filter (Coherent, Santa Clara, CA). 
The expanded collimated laser beam was focused by a convex lens at the sample.
The diameter of the focused laser beam was about 200 pm. The sample was 
contained in a melting-point capillary tube. The scattered radiation was collected at 
90° by a pair of convex lenses. The first lens was a short focal length lens used to 
maximize the collection of light. The second lens was a 14 cm convex lens used to 
match the f-number of the monochromator. A holographic rejection filter (Notch- 
Plus, Kaiser Optics, Ann Arbor, MI) was placed between these two lenses to filter 
the strong Rayleigh scattering. A double monochromator (Model GM252, Kratos 
Analytical, Chestnut Ridge, NY) system with a focal length of 25 cm and reciprocal 
linear dispersion of 3.3 nm/mm was used as the wavelength selector and to better 
reject stray radiation. A function generator (Model 8116A, Hewlett-Packard,
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Figure 26. Schematic diagram of visible Raman spectrometer.
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Houston, TX) was used to regulate the scan rate. A photomultiplier tube (PMT) 
(1P28, Hamamatsu, Bridgewater, NJ) was used as the detector. A digital 
oscilloscope and accompanying software (Model TDS620B, Tektronix, Wilsonville, 
OR) were used to digitize and acquire the data. Experimental parameters used in this 
part of the research are summarized in Table 12.
4.4.2 Raman Spectroscopy o f Common Inorganic Compounds
The Raman spectrometer was tested and optimized by observing Raman 
scattering for two common inorganic compounds: potassium nitrate (Fisher, Fairlawn, 
NJ) and potassium periodate (Sigma-Aldrich, Milwaukee, WI) and a mixture of these 
two compounds. These compounds were chosen because they give strong and well- 
defined Raman peaks. Basic optimization includes fine tuning of the sample position 
and optical components. It was determined that the Raman signal was very sensitive 
to the sample position since the Raman signal can be masked by the strong 
fluorescence signal of the glass from the melting-point capillary tube if the laser 
beam were focused onto the surface of the tube. Hence, special care was taken to 
position the sample. It was also determined that the signal can be affected by the 
length of the BNC cable connected to the output of PMT. A shorter BNC cable (~6”) 
was used to minimize the noise in the signal. The Raman spectra of these 
compounds and mixtures are shown in Figure 27.
The Raman spectra obtained by this spectrometer are comparable to those 
found in the literature [84], The minor and yet consistent difference of energies for
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Table 12. Experimental parameters for visible Raman spectroscopy
Laser wavelength 532 nm
Laser power 19 mW
Focused laser beam diameter 200 pm
Laser pulse frequency 10 Hz
Laser pulse width 6 ns
Beam expanding optics f  = -7.5 cm, f = 25 cm
Focusing lens f  = 9 cm
Collection lenses f  = 5 cm, f  = 14 cm
Resolution 5 .7 -9 .2  cm'1
Scan rate 0.55 -  1.10 cm'Vs
Averaging 30 scans
Sampling rate 1 Hz
PMT bias -990 V
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Figure 27. From top to bottom: Raman spectra of potassium nitrate, potassium 
periodate, and mixture of potassium nitrate and potassium periodate (1: KNO3, 2: 
KIO4).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
107
each peak may be due to the lack of a synchronic start of the data acquisition 
software and the monochromator scanning system.
The electronic components of this spectrometer were optimized and 
calibrated using these strong Raman scatterers. However, the optical part can only 
be roughly optimized since the optical properties such as focal length are dependent 
on the wavelength of the incident radiation. These results show that the double 
monochromator can be used for Raman spectroscopy despite its low resolution. 
Nevertheless, the optical throughput can be increased only by compromising the scan 
rate and the slit widths of the monochromator. The use of AOTFs can overcome 
such limitations because the optical aperture does not affect the resolution.
4.5 Fluorescence Spectroscopy Using Compact Deep-UV Lasers
The ultimate goal of this project was to construct a compact UV Raman 
spectrometer. To achieve this goal, a smaller laser was needed to replace the bulky 
Nd:YAG laser. Deep-UV lasers manufactured by Photon Systems were suitable for 
this purpose. These metal vapor lasers employ hollow cathode discharge metal ion 
sputtering technology, which requires no warm-up time. This technology is similar 
to that of hollow cathode lamps. The active media of these lasers are metallic ions 
generated by sputtering within the hollow cathode tube rather than thermal heating in 
conventional metal vapor lasers. A buffer gas such as helium or neon is used to 
ionize and excite these metallic ions and lasing occurs at the corresponding transition 
levels. These pulsed lasers can generate emissions at 224.3 (HeAg) and 248.6 nm
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(NeCu) with up to a 30 Hz repetition rate. No water cooling is necessary because of 
the low power consumption (<10 W). The narrow linewidth (<0.1 cm’1) of these 
lasers is ideal for Raman spectroscopy [85].
In terms of required instrumentation, Raman and fluorescence spectroscopy 
are very similar. However, fluorescence is a much stronger phenomenon than 
Raman. The intensity of a strong Raman transition is only a fraction (< 1/10000) of 
that of fluorescence. Therefore, fluorescence signal can be used to configure and 
optimize the optical configuration and electronic components for a Raman 
spectrometer.
A schematic diagram of the fluorescence spectrometer built with the compact 
deep-UV lasers is shown in Figure 28. Experimental parameters are summarized in 
Table 13. Fluorescence spectra of quinine sulfate and naphthalene were obtained 
using this system (Figure 29). The narrow peaks on top of the fluorescence band are 
plasma lines of the lasers except the 248.6 nm peak in Figure 29, which was the 
Rayleigh scattering line.
4.6 UV Raman Spectroscopy with Double Monochromators
Although fluorescence can be detected by using the deep-UV lasers, they do 
not possess enough optical power to excite the molecules and detect weak Raman 
effects. The success of visible Raman spectroscopy with the Nd:YAG laser led this 
project to the next step: Raman spectroscopy using the third harmonic generation of a












Figure 28. Schematic diagram of fluorescence experiments.
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Table 13. Experimental parameters of fluorescence experiments
Laser wavelengths 224.3 nm, 248.6 nm
Laser power 100 mW
Laser pulse frequency 5 Hz
Laser pulse width 100 ps
Collection lens f  = 14 cm
Resolution 1.7 nm
Scan rate 50 nm/min
Averaging 1-10 scans
Sampling rate 1 Hz
PMT bias -600 V
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Figure 29. Fluorescence spectra of (top) 10 ppm quinine sulfate in 1M H2SO4 (224.3 
nm excitation) and (bottom) 100 ppm naphthalene in cyclohexane (248.6 nm 
excitation).
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Nd:YAG laser and a double monochromator. The goal of this part of the project was 
to examine the characteristics of the instrumentation of UY Raman spectroscopy.
4.6.1 Experimental Setup
Two different collection geometries (90° and 180°) were examined. The 
schematic diagrams are shown in Figures 30 and 31. The third harmonic generation 
of the Nd:YAG laser (355 nm) was utilized as the UV excitation source for both 
setups. The same double monochromator and electronics as the visible setup were 
used in these spectrometers. For the 90° setup, a pair of Pellin-Broca prisms was 
used to filter the plasma lines of the laser. The beam was expanded using a pair of 
lenses before entering these prisms to confine the energy density to the tolerance of 
the prisms. A pair of convex lenses was used as the collection optics as in the visible 
setup. For the 180° setup, the laser beam was directed to the edge filter (Semrock, 
Rochester, NY) by a 355 nm laser mirror (Edmund Optics, Barrington, NJ). The 
edge filter acts as a reflective bandpass filter and a Rayleigh rejection filter for the 
transmitted light. Experimental parameters used in this part of research are 
summarized in Table 14.
4.6.2 Qualitative and Quantitative Analysis by UV Raman Spectroscopy
It was determined that the 90° geometry was better suited for liquid samples 
while the 180° geometry was better suited for solid samples. The 180° geometry















































Figure 31. Schematic diagram of UV Raman spectrometer (180° geometry).
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Table 14. Experimental parameters of the UV Raman spectrometer
Laser wavelength 355 nm
Laser power 2.5 mW
Laser pulse frequency 10 Hz
Laser pulse width 6 ns
Beam expanding optics (90° geometry) f  = -7.5 cm, f  = 20 cm 
Focusing lens (180° geometry) f  = 3 cm
Collection lenses f  = 5 cm, f  = 14 cm
Resolution 1 8 -3 2  cm'1
Scan rate 1.4 -  2.7 cm'Vs
Averaging 30 scans
Sampling rate 1 Hz
PMT bias -990 V
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always yielded a fluorescence background of the quartz sample cuvette. The 90° 
geometry was easier to set up and use for liquid samples but it is more difficult for 
solid samples if containers are used because of the fluorescence problem. More care 
in alignment and optimization was necessary for the UV system since the human eye 
cannot see the light. A business card that fluoresced in the presence of UV laser 
radiation was often used for alignment.
Raman spectra of pure acetonitrile, a solution mixture of acetonitrile and 
potassium nitrate, and solid potassium nitrate were obtained utilizing this Raman 
system (Figure 32). The spectrum of the solution mixture (Figure 32) clearly shows 
the characteristic water band at 3400 cm'1. The broad band spanning from 150 to 
650 cm'1 of the solid potassium nitrate spectrum (Figure 32) may arise from an 
unknown impurity in the sample. Quantitative analysis was demonstrated by 
analyzing various potassium nitrate solutions (Figure 33). A calibration plot based 
on the 1055 cm'1 peak was obtained (Figure 34) and it shows a good linear 
relationship (R2 = 0.997). The detection limit was about 20 mM for this compound. 
This shows that quantitative analysis was feasible with UV Raman spectroscopy 
although the sensitivity was not very good; however, it may be more sensitive for 
compounds that exhibit a resonance Raman effect in the UV region.
4.7 UV AOTF Experiments
In this part of the research, experiments combining a UV AOTF and a double 
monochromator were attempted. The feasibility of using UV AOTF for Raman
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Figure 32. From top to bottom: Raman spectra of acetonitrile (90° geometry), 
mixture of potassium nitrate and acetonitrile (90° geometry), and solid potassium 
nitrate (180° geometry).
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Figure 33. Raman spectra of various potassium nitrate solutions.
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Figure 34. Calibration plot of potassium nitrate solutions.
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spectroscopy is evaluated. A UV AOTF was used initially to replace the double 
monochromator directly for Raman spectroscopy. However, no Raman scattering 
could be detected using the AOTF alone. Excessive stray light of the system was 
postulated as the major reason for undetectable Raman signal. Hence, the double 
monochromator was inserted after the AOTF for more effective stray light rejection 
and to attempt to optimize the optics (Figure 35).
The UV AOTF used in this research was a quartz collinear device (Model 
QZAF 0.2-0.4, Brimrose, Baltimore, MD) with a spectral range from 200 to 400 nm. 
The size of the AOTF was 6 x 8 x 4 cm with a 3 x 3 mm optical aperture. The 
maximum acceptance angle was 7 degrees and the manufactured specified diffraction 
efficiency was 20 %. Since the AOTF was collinear, a Glan-Taylor polarizer (Karl 
Lambrecht, Chicago, IL) was used to select the diffracted light before entering the 
monochromator. Higher laser power (1 W) was used to ensure sufficient excitation 
photons. Larger slit widths were used to ensure more Raman photons were reaching 
the detector. Detailed experimental parameters are summarized in Table 15.
Acetone was chosen as the sample because it gives a strong peak at 2950 cm'1, 
far away from the Rayleigh scattering peak. Two sets of experiments were 
performed using this system. The first set of experiments applied the double 
monochromator as the wavelength selector and the AOTF as the stray light rejecter.
In this set of experiments, the AOTF was set at the center wavelength of an acetone 
peak (2950 cm'1) while the monochromator was scanning across the peak (Figure 36). 
The second set of experiments applied the AOTF as the wavelength selector and the 
monochromator as the stray light rejecter. In this set of experiments, the























Figure 35. UV AOTF Raman setup with double monochromator.
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Figure 36. Raman spectra of acetone (top: Scan the monochromator, set the AOTF at 
2950 cm'1; bottom: scan the AOTF, set the monochromator at 2950 cm'1).
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monochromator was set at the center wavelength of an acetone peak while the AOTF 
was scanning across the peak (Figure 36).
The difference between the spectra obtained by the two settings showed that 
the UV AOTF was not able to filter the Raman signal from the background signal. 
Since the scattered light from the sample was unpolarized in nature, a second 
polarizer was placed between the sample and the AOTF (Figure 37) to filter one of 
the polarizations and other unwanted background signals such as Rayleigh scattering. 
Four different experiments were performed to verify the functionality of the AOTF. 
First, a spectrum was obtained by setting the monochromator at the 2950 cm’1 
acetone peak while scanning the AOTF from about 200 to 3300 cm’1 (Figure 38). 
Second, a spectrum was obtained by setting the AOTF at the 2950 cm'1 peak while 
scanning the monochromator from about 300 to 3400 cm’1 (Figure 38). Third, a 
spectrum was obtained by setting the AOTF at 2250 cm’1 (background) while 
scanning the monochromator from about 300 to 3400 cm’1 (Figure 39). Finally, a 
spectrum was obtained by turning off the AOTF and repeating the scan (Figure 39). 
The similarity of the last three spectra reveals that the AOTF did not filter the Raman 
light from the background light. It is likely that the observed features are reflected 
rather than diffracted by the optics and polarizers.
Although no Raman signal was detected with the UV AOTF, Rayleigh 
scattering can be detected using the UV AOTF without the edge filters. The 
experimental setup is shown in Figure 40 and the acetone Rayleigh spectrum is 
shown in Figure 41. The signal-to-noise ratio (S/N) was 23 and 80 for the single 
scan and the average of 10 scans respectively. This low S/N shows that it is very
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Figure 38. Acetone Raman spectra of the first two experiments associated to Figure 
37. Top: Scan the AOTF, set the monochromator at 2950 cm'1; bottom: scan the 
monochromator, set the AOTF at 2950 cm'1.
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Figure 39. Acetone Raman spectra the last two experiments associated to Figure 37. 
Top: Scan the monochromator, set the AOTF at 2250 cm'1; bottom: scan the 
monochromator, turn the AOTF off.
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Figure 41. Acetone Rayleigh spectrum (top: 10 scans, bottom: 1 scan).
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unlikely to observe Raman scattering using UV AOTF because the Raman signal is 
at least 10,000 times less intense than the Rayleigh signal. If the noise of Rayleigh 
scattering is approximately equal to the noise of Raman scattering, the S/N for 
Raman would be at most 80/10,000 or 0.008. A detectable S/N would generally be > 
3; hence, the signal of Raman scattering must be increased by at least 3/0.008 or 375 
times in order to be detectable. Using signal averaging, this means that at least 
(375)2(10) or 1,406,250 spectra would be needed to accomplish this S/N. Clearly, 
this is not practical.
4.8 Conclusions
Although the application of UV AOTF for Raman spectroscopy was not 
successful, valuable insights have been gained during the course of this research. It 
was determined that the limiting factor for the infeasibility was the high background 
signal. This dominates the much weaker Raman signal. It is possible that a major 
contribution to this background was the unpolarized light leaking from the polarizers. 
The efficiency factor for the polarizers is 0.001 %.
For future considerations, the Raman S/N may be improved by reducing the 
laser power fluctuation and reducing detector noise. However, the focus should be 
on the reduction of the background signal and noise. The Raman S/N can be greatly 
improved if the background Rayleigh and laser-scattering signal can be decreased 
while the Raman signal is retained.
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Several approaches may be considered to reduce this background signal. One 
may use another polarizer to filter more undiffracted light. However, this approach 
will also diminish the Raman signal. The leakage of the unpolarized light from the 
polarizers was postulated as the major source of the high background signal. 
Therefore, the focus should be on the elimination of this leakage. One way to solve 
this problem may be using a noncollinear AOTF. The diffracted light is separated in 
space from the undiffracted light so polarizers are not needed. If this approach 
reduces the background significantly, one may conclude the major contribution of 
the background comes from the leakage of the polarizer. Otherwise, other factors 
such as the excitation source and the detectors should be considered. More stable 
lasers may be used to reduce the background fluctuation. Cooling of the PMT may 
also help to lower the thermal noise. PMTs that have lower dark current may also be 
considered.
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CHAPTER 5
OVERALL CONCLUSIONS AND FUTURE CONSIDERATIONS
This dissertation documents the application and development of various 
analytical techniques for the determination and quantification of active 
pharmaceutical ingredients. Three research projects were described. Different foci 
were set for each of these projects.
The first project demonstrated the use of inductively coupled plasma mass 
spectrometry combined with ultrasonic nebulization—membrane desolvation for 
sample introduction to determine and quantify phosphorus, sulfur, chlorine and 
fluorine heteroatom-containing active pharmaceutical ingredients. Low detection 
limits and high selectivity of elemental nonmetal detection were obtained using this 
technique.
ICP-MS possesses great potential for the pharmaceutical industry because of 
its high sensitivity and selectivity. Further improvements in sample introduction 
should make this technique more powerful in terms of analytical performance for the 
determination of trace impurities in active pharmaceutical ingredients. Such 
improvements might require fundamental understanding of sample introduction 
systems such as the physical and chemical properties of the membrane desolvator.
The second project demonstrated the application of dispersive Raman
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spectroscopy and chemometrics to determine and quantity acetaminophen, 
guaifenesin, and phenylephrine hydrochloride in an over-the-counter pharmaceutical 
product. The advantages of Raman spectroscopy, such as nondestructive sampling 
and minimal to no sample preparation, combined with the robust nature of 
chemometrics offers an efficient alternative method for quantitative pharmaceutical 
analysis.
Quantification is more reliable and robust with the help of chemometrics. 
Since a Raman spectrum contains rich molecular and structural information for a 
compound or mixture of compounds, it also can be used as a pattern recognition and 
classification technique for more complex systems or mixtures. Although normal 
Raman scattering is a weak phenomenon, Raman intensity can be enhanced greatly 
using surface-enhanced Raman spectroscopy (SERS) [86]. The enhanced sensitivity 
of SERS definitely makes it an attractive technique for the determination and 
quantification of minor impurities in pharmaceutical products.
The third project evaluated the feasibility of the development of an ultra­
violet acousto-optic tunable-filter Raman spectrometer. High background signal 
from Rayleigh and laser scattering was determined to be the limiting factor causing 
the Raman signal to be undetectable using this UV AOTF.
A better understanding of the origins of background signal is essentially the 
key for obtaining a detectable Raman signal using a UV AOTF. A major 
contribution to this background was hypothesized to be the unpolarized light leaking 
from the polarizers. Noncollinear UV AOTFs have been introduced for 
spectroscopic applications [80]. Such AOTFs may be used instead of collinear
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134
models for Raman spectroscopy because noncollinear AOTFs do not require 
polarizers for the filtering of the undiffracted beam and because the diffracted beam 
is separated in space from the undiffracted beam.
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